GS	SIZE	SOURCE	ES	NES	NOM p-val	FDR q-val	FWER p-val	Tag %	Gene %	Signal	FDR (median)	glob.p.val
OXFORD_RALA_OR_RALB_TARGETS_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/OXFORD_RALA_OR_RALB_TARGETS_UP	-0.80724	-1.7063	0.001949	1	0.742	0.667	0.111	0.594	0.78163	0.416
GENTLES_LEUKEMIC_STEM_CELL_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/GENTLES_LEUKEMIC_STEM_CELL_DN	-0.70841	-1.7027	0.007797	0.81006	0.752	0.263	0.0431	0.252	0.40829	0.221
KONG_E2F3_TARGETS	91	http://www.broadinstitute.org/gsea/msigdb/cards/KONG_E2F3_TARGETS	-0.78835	-1.6965	0.008147	0.58931	0.773	0.582	0.074	0.542	0.29789	0.134
LEE_EARLY_T_LYMPHOCYTE_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_UP	-0.78765	-1.6949	0.009881	0.4505	0.775	0.578	0.0272	0.566	0.23094	0.092
NADERI_BREAST_CANCER_PROGNOSIS_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/NADERI_BREAST_CANCER_PROGNOSIS_UP	-0.74035	-1.6897	0.009862	0.38382	0.79	0.591	0.151	0.503	0.1981	0.07
BURTON_ADIPOGENESIS_3	101	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_3	-0.71913	-1.6793	0.01394	0.3668	0.822	0.545	0.0816	0.503	0.2003	0.07
WHITFIELD_CELL_CYCLE_LITERATURE	44	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_LITERATURE	-0.83365	-1.6683	0	0.36491	0.843	0.591	0.0525	0.561	0.20209	0.066
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	137	http://www.broadinstitute.org/gsea/msigdb/cards/ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-0.84213	-1.6651	0	0.33045	0.847	0.701	0.0631	0.661	0.18406	0.062
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	-0.84635	-1.6649	0	0.29486	0.848	0.471	0.0317	0.456	0.16415	0.054
AMUNDSON_GAMMA_RADIATION_RESPONSE	39	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GAMMA_RADIATION_RESPONSE	-0.85147	-1.6619	0.002012	0.27575	0.853	0.615	0.0411	0.591	0.15302	0.046
HU_GENOTOXIC_DAMAGE_4HR	35	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_4HR	-0.68518	-1.6591	0.0121	0.26023	0.863	0.4	0.0296	0.389	0.14637	0.041
WHITEFORD_PEDIATRIC_CANCER_MARKERS	110	http://www.broadinstitute.org/gsea/msigdb/cards/WHITEFORD_PEDIATRIC_CANCER_MARKERS	-0.76754	-1.6466	0.01411	0.28188	0.895	0.6	0.0793	0.555	0.16265	0.047
SIMBULAN_PARP1_TARGETS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_PARP1_TARGETS_DN	-0.82429	-1.6438	0.004	0.26968	0.9	0.588	0.0931	0.534	0.15761	0.045
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-0.632	-1.6404	0.02687	0.26164	0.911	0.433	0.0674	0.406	0.15045	0.045
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	-0.73831	-1.639	0.003937	0.24843	0.911	0.579	0.0788	0.534	0.14222	0.038
FURUKAWA_DUSP6_TARGETS_PCI35_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_DN	-0.66716	-1.6364	0.0233	0.24012	0.918	0.391	0.0321	0.38	0.13702	0.033
CROONQUIST_IL6_DEPRIVATION_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_DN	-0.76767	-1.636	0.007905	0.22708	0.919	0.612	0.0727	0.57	0.13047	0.03
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-0.7804	-1.6304	0.0137	0.22814	0.931	0.599	0.0816	0.554	0.13252	0.031
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	54	http://www.broadinstitute.org/gsea/msigdb/cards/WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.74232	-1.6242	0.0293	0.23349	0.94	0.556	0.0601	0.524	0.13698	0.031
TANG_SENESCENCE_TP53_TARGETS_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/TANG_SENESCENCE_TP53_TARGETS_DN	-0.75821	-1.6221	0.02405	0.22753	0.943	0.579	0.055	0.549	0.13542	0.029
MORI_PRE_BI_LYMPHOCYTE_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PRE_BI_LYMPHOCYTE_UP	-0.64735	-1.6216	0.03578	0.21832	0.944	0.423	0.0655	0.397	0.13021	0.028
KOBAYASHI_EGFR_SIGNALING_24HR_DN	240	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_24HR_DN	-0.66796	-1.6177	0.02519	0.21797	0.949	0.479	0.0816	0.445	0.1336	0.027
KANG_DOXORUBICIN_RESISTANCE_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_UP	-0.86811	-1.6147	0.005976	0.21572	0.953	0.811	0.0871	0.743	0.12944	0.026
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	-0.70245	-1.6124	0.028	0.21217	0.955	0.531	0.121	0.467	0.12821	0.025
PID_FOXM1_PATHWAY	40	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FOXM1_PATHWAY	-0.63136	-1.6116	0.03386	0.19808	0.959	0.375	0.0692	0.35	0.1196	0.022
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	-0.74751	-1.6116	0.004	0.20597	0.959	0.4	0.0137	0.395	0.12438	0.024
WEBER_METHYLATED_ICP_IN_FIBROBLAST	20	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_ICP_IN_FIBROBLAST	-0.68866	-1.6101	0.005929	0.19416	0.96	0.35	0.214	0.275	0.1177	0.021
BURTON_ADIPOGENESIS_PEAK_AT_24HR	42	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_24HR	-0.70445	-1.603	0.03143	0.20315	0.966	0.429	0.0255	0.419	0.12523	0.022
YU_MYC_TARGETS_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/YU_MYC_TARGETS_UP	-0.74455	-1.601	0.02414	0.20143	0.97	0.462	0.0255	0.451	0.12462	0.022
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	166	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-0.65638	-1.6005	0.03386	0.19597	0.97	0.428	0.035	0.416	0.12071	0.021
LY_AGING_MIDDLE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_MIDDLE_DN	-0.85648	-1.5993	0.006061	0.19214	0.971	0.688	0.0588	0.648	0.11875	0.021
ZHAN_MULTIPLE_MYELOMA_PR_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_UP	-0.89161	-1.5976	0	0.19011	0.972	0.744	0.0272	0.725	0.11723	0.02
GAVIN_FOXP3_TARGETS_CLUSTER_P6	87	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P6	-0.65974	-1.5964	0.02178	0.18689	0.973	0.529	0.0883	0.484	0.1161	0.019
FARMER_BREAST_CANCER_CLUSTER_2	32	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_2	-0.88046	-1.5945	0.007905	0.18532	0.977	0.656	0.0255	0.641	0.11476	0.018
REICHERT_MITOSIS_LIN9_TARGETS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REICHERT_MITOSIS_LIN9_TARGETS	-0.83002	-1.5925	0.007937	0.1846	0.978	0.615	0.0411	0.591	0.11309	0.018
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	-0.77708	-1.5918	0.01603	0.18071	0.979	0.524	0.0414	0.503	0.11049	0.017
VECCHI_GASTRIC_CANCER_EARLY_UP	396	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_EARLY_UP	-0.58142	-1.5882	0.03314	0.18353	0.98	0.432	0.108	0.393	0.1139	0.018
CHANG_CYCLING_GENES	140	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CYCLING_GENES	-0.70504	-1.5876	0.03373	0.18	0.98	0.6	0.106	0.54	0.11125	0.017
CROONQUIST_NRAS_SIGNALING_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_SIGNALING_DN	-0.76142	-1.5865	0.02994	0.17772	0.982	0.611	0.0752	0.567	0.11071	0.017
ISHIDA_E2F_TARGETS	51	http://www.broadinstitute.org/gsea/msigdb/cards/ISHIDA_E2F_TARGETS	-0.78932	-1.5857	0.008065	0.17525	0.982	0.588	0.0599	0.554	0.10824	0.017
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-0.61127	-1.5822	0.04418	0.17757	0.984	0.399	0.083	0.368	0.11073	0.017
SHEPARD_BMYB_TARGETS	67	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_TARGETS	-0.6276	-1.5795	0.04339	0.1786	0.984	0.418	0.0626	0.393	0.11146	0.017
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	-0.67808	-1.579	0.02505	0.17527	0.984	0.558	0.0845	0.513	0.10941	0.017
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	309	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	-0.61198	-1.577	0.0404	0.17534	0.986	0.453	0.0937	0.417	0.1096	0.017
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.73626	-1.5647	0.02429	0.19652	0.99	0.6	0.0858	0.55	0.12311	0.018
KAUFFMANN_MELANOMA_RELAPSE_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_MELANOMA_RELAPSE_UP	-0.68025	-1.5616	0.03762	0.1989	0.992	0.492	0.0846	0.451	0.12466	0.018
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	-0.64626	-1.5608	0.02794	0.19601	0.992	0.406	0.0871	0.371	0.1227	0.018
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	82	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-0.68833	-1.5565	0.03984	0.20113	0.993	0.476	0.0793	0.44	0.12784	0.018
DELPUECH_FOXO3_TARGETS_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/DELPUECH_FOXO3_TARGETS_DN	-0.5881	-1.5494	0.04374	0.21254	0.994	0.35	0.0588	0.33	0.13627	0.021
BENPORATH_ES_2	37	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_2	-0.53969	-1.5435	0.04314	0.22141	0.995	0.297	0.0555	0.281	0.14347	0.023
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	-0.64652	-1.5274	0.04573	0.25672	0.996	0.316	0.0243	0.308	0.16675	0.029
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-0.64398	-1.5272	0.05754	0.25227	0.996	0.42	0.0846	0.385	0.16487	0.029
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	122	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-0.64215	-1.5247	0.07129	0.25408	0.998	0.475	0.0846	0.438	0.16653	0.029
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	86	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-0.7239	-1.5246	0.05389	0.24969	0.998	0.512	0.0317	0.498	0.16345	0.029
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	94	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-0.48834	-1.5243	0.04192	0.24572	0.998	0.33	0.0849	0.303	0.16081	0.026
LE_NEURONAL_DIFFERENTIATION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/LE_NEURONAL_DIFFERENTIATION_DN	-0.71807	-1.5243	0.03808	0.24148	0.998	0.579	0.062	0.544	0.15794	0.024
LI_WILMS_TUMOR_ANAPLASTIC_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_ANAPLASTIC_UP	-0.75027	-1.5213	0.02745	0.24463	0.999	0.579	0.083	0.531	0.16197	0.024
HATADA_METHYLATED_IN_LUNG_CANCER_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/HATADA_METHYLATED_IN_LUNG_CANCER_DN	-0.54924	-1.5191	0.02817	0.24626	0.999	0.364	0.175	0.3	0.16056	0.024
MORI_IMMATURE_B_LYMPHOCYTE_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_IMMATURE_B_LYMPHOCYTE_DN	-0.67241	-1.5181	0.04713	0.24469	0.999	0.466	0.0781	0.431	0.16017	0.024
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-0.64804	-1.516	0.06314	0.24614	0.999	0.41	0.0714	0.382	0.16098	0.025
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	172	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_CRUSH_AND_BURN_MUTANT_DN	-0.47754	-1.5157	0.05315	0.24262	0.999	0.32	0.0875	0.294	0.15834	0.023
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	116	http://www.broadinstitute.org/gsea/msigdb/cards/MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-0.59342	-1.5132	0.05859	0.24482	0.999	0.353	0.0603	0.334	0.16023	0.025
GREENBAUM_E2A_TARGETS_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/GREENBAUM_E2A_TARGETS_UP	-0.72867	-1.5113	0.06374	0.24565	0.999	0.606	0.0699	0.565	0.16166	0.023
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	178	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-0.60011	-1.511	0.05964	0.24251	0.999	0.376	0.0317	0.368	0.15949	0.021
EGUCHI_CELL_CYCLE_RB1_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.85372	-1.5108	0.01613	0.23924	0.999	0.913	0.121	0.803	0.15719	0.021
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	-0.74357	-1.5047	0.0505	0.25037	0.999	0.636	0.0599	0.599	0.16329	0.024
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	-0.55485	-1.5028	0.06154	0.25134	0.999	0.313	0.0244	0.307	0.16532	0.024
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-0.68995	-1.5013	0.05743	0.25104	0.999	0.558	0.0599	0.526	0.16688	0.023
SMID_BREAST_CANCER_LUMINAL_A_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_A_DN	-0.83083	-1.5007	0.03175	0.24892	0.999	0.647	0.0793	0.596	0.16549	0.022
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	45	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	-0.62674	-1.4989	0.09785	0.24967	0.999	0.4	0.095	0.363	0.16713	0.024
LE_EGR2_TARGETS_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/LE_EGR2_TARGETS_UP	-0.58074	-1.4889	0.06324	0.27106	1	0.491	0.104	0.442	0.18121	0.027
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	164	http://www.broadinstitute.org/gsea/msigdb/cards/SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-0.57101	-1.4884	0.06496	0.26841	1	0.378	0.0752	0.352	0.18014	0.026
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	-0.65976	-1.4882	0.04508	0.26513	1	0.4	0.0157	0.394	0.17779	0.025
PID_PLK1_PATHWAY	44	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PLK1_PATHWAY	-0.60189	-1.4796	0.09677	0.28398	1	0.386	0.0397	0.372	0.19138	0.031
FINETTI_BREAST_CANCER_KINOME_RED	16	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_RED	-0.84221	-1.4786	0.03704	0.28297	1	0.812	0.11	0.724	0.19119	0.031
ODONNELL_TFRC_TARGETS_DN	132	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_DN	-0.57074	-1.4773	0.07927	0.28231	1	0.379	0.0721	0.354	0.19023	0.03
REACTOME_G0_AND_EARLY_G1	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G0_AND_EARLY_G1	-0.65468	-1.4729	0.07172	0.29028	1	0.348	0.0461	0.332	0.19665	0.031
BASAKI_YBX1_TARGETS_UP	276	http://www.broadinstitute.org/gsea/msigdb/cards/BASAKI_YBX1_TARGETS_UP	-0.53414	-1.4722	0.05976	0.2849	1	0.373	0.0816	0.347	0.19353	0.03
SONG_TARGETS_OF_IE86_CMV_PROTEIN	59	http://www.broadinstitute.org/gsea/msigdb/cards/SONG_TARGETS_OF_IE86_CMV_PROTEIN	-0.63182	-1.4722	0.0754	0.28853	1	0.441	0.121	0.388	0.19601	0.03
RHODES_UNDIFFERENTIATED_CANCER	67	http://www.broadinstitute.org/gsea/msigdb/cards/RHODES_UNDIFFERENTIATED_CANCER	-0.65288	-1.4657	0.1043	0.29911	1	0.403	0.0699	0.376	0.203	0.033
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	309	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	-0.48244	-1.4645	0.0239	0.29865	1	0.589	0.254	0.446	0.20113	0.033
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	190	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CISPLATIN_RESPONSE_AND_XPC_UP	-0.42471	-1.4642	0.0268	0.2958	1	0.295	0.105	0.266	0.1988	0.031
REACTOME_KINESINS	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KINESINS	-0.6284	-1.4639	0.08634	0.29299	1	0.391	0.0744	0.363	0.19684	0.031
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	-0.73411	-1.458	0.06312	0.30525	1	0.688	0.147	0.587	0.20656	0.033
SU_TESTIS	74	http://www.broadinstitute.org/gsea/msigdb/cards/SU_TESTIS	-0.52766	-1.4495	0.1053	0.32509	1	0.23	0.035	0.223	0.22252	0.044
REN_BOUND_BY_E2F	60	http://www.broadinstitute.org/gsea/msigdb/cards/REN_BOUND_BY_E2F	-0.63602	-1.4479	0.09256	0.32592	1	0.517	0.121	0.455	0.22209	0.044
NAKAMURA_CANCER_MICROENVIRONMENT_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_CANCER_MICROENVIRONMENT_DN	-0.59713	-1.4432	0.08713	0.33578	1	0.381	0.0676	0.356	0.23272	0.045
BIOCARTA_G2_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_G2_PATHWAY	-0.52803	-1.4335	0.06587	0.36062	1	0.292	0.059	0.275	0.25168	0.052
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-0.53471	-1.4303	0.08055	0.36603	1	0.366	0.0862	0.337	0.25473	0.052
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	-0.58224	-1.4259	0.09369	0.37568	1	0.533	0.121	0.469	0.26333	0.058
FERRANDO_HOX11_NEIGHBORS	23	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_HOX11_NEIGHBORS	-0.53548	-1.4213	0.07984	0.38576	1	0.261	0.0224	0.255	0.26921	0.062
FAELT_B_CLL_WITH_VH3_21_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH3_21_UP	-0.49406	-1.4212	0.06	0.38191	1	0.643	0.283	0.462	0.2664	0.06
VANTVEER_BREAST_CANCER_METASTASIS_DN	111	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_METASTASIS_DN	-0.5987	-1.4189	0.09761	0.38484	1	0.396	0.0715	0.37	0.26772	0.062
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	432	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	-0.53263	-1.4167	0.1122	0.38796	1	0.38	0.0968	0.35	0.26612	0.063
ZHANG_TLX_TARGETS_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_UP	-0.59894	-1.4147	0.1364	0.39018	1	0.442	0.0752	0.41	0.26887	0.065
SHEPARD_BMYB_MORPHOLINO_DN	188	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_MORPHOLINO_DN	-0.41157	-1.4123	0.07647	0.39393	1	0.255	0.0626	0.242	0.27109	0.065
SMIRNOV_RESPONSE_TO_IR_6HR_DN	109	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_6HR_DN	-0.51077	-1.4096	0.066	0.39831	1	0.266	0.048	0.255	0.27387	0.067
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	-0.57122	-1.4066	0.08748	0.39992	1	0.345	0.028	0.336	0.2761	0.067
STANELLE_E2F1_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/STANELLE_E2F1_TARGETS	-0.50661	-1.4066	0.06744	0.4039	1	0.379	0.0956	0.344	0.27892	0.069
REACTOME_LIPOPROTEIN_METABOLISM	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIPOPROTEIN_METABOLISM	-0.50563	-1.4017	0.06762	0.41158	1	0.357	0.129	0.311	0.28779	0.07
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	18	http://www.broadinstitute.org/gsea/msigdb/cards/HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	-0.57365	-1.4017	0.09925	0.40773	1	0.556	0.0692	0.518	0.2858	0.069
VERNELL_RETINOBLASTOMA_PATHWAY_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/VERNELL_RETINOBLASTOMA_PATHWAY_UP	-0.55329	-1.3954	0.1193	0.42447	1	0.412	0.0876	0.377	0.29935	0.076
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	-0.63493	-1.3944	0.07784	0.42366	1	0.6	0.156	0.507	0.29795	0.075
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	154	http://www.broadinstitute.org/gsea/msigdb/cards/WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-0.5673	-1.3881	0.1625	0.44034	1	0.422	0.0969	0.384	0.30736	0.083
PETROVA_PROX1_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_PROX1_TARGETS_UP	-0.61121	-1.386	0.1277	0.44271	1	0.423	0.0419	0.406	0.31024	0.084
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	-0.51338	-1.3822	0.1206	0.45136	1	0.398	0.12	0.352	0.31716	0.085
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	17	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	-0.5648	-1.3771	0.07976	0.46396	1	0.471	0.183	0.385	0.33072	0.084
BENPORATH_PROLIFERATION	138	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_PROLIFERATION	-0.55425	-1.3769	0.1474	0.4605	1	0.362	0.083	0.334	0.32766	0.083
MARKEY_RB1_ACUTE_LOF_DN	219	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_DN	-0.47318	-1.3687	0.1348	0.48413	1	0.311	0.0707	0.292	0.34958	0.093
WONG_ENDMETRIUM_CANCER_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_ENDMETRIUM_CANCER_UP	-0.65409	-1.3676	0.07102	0.4837	1	0.5	0.17	0.415	0.34784	0.092
BENPORATH_ES_CORE_NINE_CORRELATED	100	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_CORE_NINE_CORRELATED	-0.45775	-1.3649	0.1273	0.48872	1	0.34	0.0989	0.308	0.353	0.094
LIN_APC_TARGETS	75	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_APC_TARGETS	-0.47298	-1.3644	0.09237	0.48612	1	0.573	0.244	0.435	0.35092	0.092
MURAKAMI_UV_RESPONSE_24HR	19	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_24HR	-0.53533	-1.3595	0.1078	0.49857	1	0.368	0.13	0.321	0.35994	0.097
ZHANG_TLX_TARGETS_60HR_DN	263	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_60HR_DN	-0.50044	-1.3584	0.1551	0.49823	1	0.357	0.0905	0.329	0.36069	0.094
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	-0.51516	-1.358	0.06863	0.49514	1	0.375	0.105	0.336	0.35755	0.093
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HDL_MEDIATED_LIPID_TRANSPORT	-0.585	-1.3575	0.1426	0.49291	1	0.467	0.187	0.379	0.35508	0.093
NIELSEN_SYNOVIAL_SARCOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SYNOVIAL_SARCOMA_UP	-0.58707	-1.3569	0.1071	0.49059	1	0.611	0.183	0.5	0.35408	0.091
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/PODAR_RESPONSE_TO_ADAPHOSTIN_DN	-0.5396	-1.3552	0.09709	0.49214	1	0.412	0.0564	0.389	0.35564	0.092
AFFAR_YY1_TARGETS_DN	225	http://www.broadinstitute.org/gsea/msigdb/cards/AFFAR_YY1_TARGETS_DN	-0.41728	-1.3551	0.09234	0.48846	1	0.307	0.106	0.277	0.35361	0.089
YU_BAP1_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/YU_BAP1_TARGETS	-0.5607	-1.3535	0.1359	0.48965	1	0.379	0.0692	0.354	0.35462	0.09
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	-0.5695	-1.3521	0.09298	0.49022	1	0.48	0.109	0.428	0.35399	0.09
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	361	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	-0.41771	-1.352	0.114	0.48654	1	0.355	0.14	0.31	0.35109	0.089
BIOCARTA_MCM_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MCM_PATHWAY	-0.60451	-1.351	0.1384	0.48619	1	0.611	0.121	0.537	0.35166	0.088
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	19	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_9	-0.54412	-1.3459	0.08519	0.49949	1	0.368	0.135	0.319	0.35974	0.091
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	36	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	-0.53404	-1.3458	0.1573	0.49581	1	0.611	0.243	0.464	0.35748	0.089
PID_DELTA_NP63_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_DELTA_NP63_PATHWAY	-0.43643	-1.3405	0.1062	0.51008	1	0.244	0.0714	0.228	0.36945	0.096
KAMMINGA_EZH2_TARGETS	41	http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_EZH2_TARGETS	-0.62112	-1.3398	0.1815	0.50835	1	0.463	0.0773	0.428	0.36803	0.095
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	335	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	-0.42055	-1.3391	0.1512	0.50701	1	0.334	0.124	0.298	0.36811	0.094
BLUM_RESPONSE_TO_SALIRASIB_DN	335	http://www.broadinstitute.org/gsea/msigdb/cards/BLUM_RESPONSE_TO_SALIRASIB_DN	-0.43447	-1.339	0.1373	0.50342	1	0.272	0.0597	0.26	0.36547	0.092
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	248	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	-0.41502	-1.3379	0.1235	0.50334	1	0.375	0.145	0.324	0.36612	0.09
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	-0.45533	-1.3279	0.1292	0.53321	1	0.356	0.0978	0.321	0.38851	0.111
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	-0.47991	-1.3271	0.152	0.53201	1	0.324	0.069	0.302	0.38908	0.11
REACTOME_MITOTIC_PROMETAPHASE	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_PROMETAPHASE	-0.48616	-1.325	0.1892	0.53509	1	0.296	0.0793	0.274	0.39018	0.112
BURTON_ADIPOGENESIS_PEAK_AT_16HR	40	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_16HR	-0.5129	-1.3224	0.1601	0.54014	1	0.55	0.136	0.476	0.39566	0.114
MORI_MATURE_B_LYMPHOCYTE_DN	70	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_MATURE_B_LYMPHOCYTE_DN	-0.45465	-1.3199	0.1215	0.54449	1	0.3	0.0714	0.28	0.39811	0.118
MANALO_HYPOXIA_DN	267	http://www.broadinstitute.org/gsea/msigdb/cards/MANALO_HYPOXIA_DN	-0.46045	-1.3198	0.1882	0.54087	1	0.333	0.122	0.296	0.39548	0.114
REACTOME_RNA_POL_I_PROMOTER_OPENING	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_PROMOTER_OPENING	-0.56855	-1.3195	0.1811	0.53828	1	0.486	0.238	0.372	0.39521	0.113
PYEON_HPV_POSITIVE_TUMORS_UP	93	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_HPV_POSITIVE_TUMORS_UP	-0.51816	-1.3184	0.196	0.53788	1	0.376	0.101	0.34	0.39514	0.113
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	154	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-0.49572	-1.315	0.1793	0.54594	1	0.357	0.0836	0.33	0.3997	0.118
JAEGER_METASTASIS_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/JAEGER_METASTASIS_UP	-0.53006	-1.314	0.157	0.54522	1	0.439	0.0945	0.398	0.40198	0.117
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	-0.49732	-1.3112	0.1733	0.551	1	0.262	0.0599	0.247	0.40627	0.121
JEON_SMAD6_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/JEON_SMAD6_TARGETS_DN	-0.60621	-1.3096	0.1739	0.55239	1	0.474	0.109	0.422	0.40714	0.122
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	-0.48739	-1.3086	0.1736	0.55208	1	0.4	0.136	0.346	0.40889	0.122
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	-0.53001	-1.3073	0.1409	0.55266	1	0.32	0.035	0.309	0.40965	0.122
TERAMOTO_OPN_TARGETS_CLUSTER_7	19	http://www.broadinstitute.org/gsea/msigdb/cards/TERAMOTO_OPN_TARGETS_CLUSTER_7	-0.55336	-1.3032	0.1529	0.56233	1	0.368	0.0828	0.338	0.41668	0.126
FUJII_YBX1_TARGETS_DN	195	http://www.broadinstitute.org/gsea/msigdb/cards/FUJII_YBX1_TARGETS_DN	-0.50017	-1.3028	0.1881	0.56009	1	0.431	0.0941	0.394	0.41599	0.125
WHITFIELD_CELL_CYCLE_G2	168	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2	-0.42761	-1.3025	0.1497	0.5571	1	0.327	0.0848	0.302	0.41339	0.123
GOUYER_TATI_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GOUYER_TATI_TARGETS_DN	-0.62306	-1.3007	0.1802	0.55958	1	0.467	0.0727	0.433	0.41824	0.122
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	24	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_5P15_AMPLICON	-0.48174	-1.2968	0.1638	0.56896	1	0.333	0.119	0.294	0.42554	0.13
LY_AGING_PREMATURE_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_PREMATURE_DN	-0.55945	-1.2964	0.1807	0.56652	1	0.345	0.0655	0.323	0.42546	0.127
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	-0.41829	-1.2947	0.09148	0.56867	1	0.312	0.0816	0.287	0.42644	0.129
CHEN_ETV5_TARGETS_TESTIS	21	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_ETV5_TARGETS_TESTIS	-0.59117	-1.287	0.2012	0.59121	1	0.429	0.0723	0.398	0.44979	0.138
LU_TUMOR_ANGIOGENESIS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_ANGIOGENESIS_UP	-0.54996	-1.2851	0.1785	0.59365	1	0.48	0.0828	0.441	0.44934	0.14
RIZ_ERYTHROID_DIFFERENTIATION	73	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION	-0.4224	-1.2813	0.1765	0.60304	1	0.315	0.104	0.283	0.45927	0.146
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	-0.46427	-1.281	0.2159	0.59999	1	0.406	0.188	0.33	0.45712	0.143
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	-0.51666	-1.2787	0.1723	0.60412	1	0.435	0.256	0.324	0.45944	0.146
MITSIADES_RESPONSE_TO_APLIDIN_DN	241	http://www.broadinstitute.org/gsea/msigdb/cards/MITSIADES_RESPONSE_TO_APLIDIN_DN	-0.44294	-1.2785	0.202	0.60114	1	0.261	0.0509	0.251	0.45714	0.144
PID_AURORA_A_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AURORA_A_PATHWAY	-0.45364	-1.278	0.1409	0.59881	1	0.267	0.059	0.251	0.45533	0.142
REACTOME_DNA_STRAND_ELONGATION	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_STRAND_ELONGATION	-0.52273	-1.2765	0.2244	0.60008	1	0.433	0.121	0.381	0.45821	0.141
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	-0.56162	-1.2712	0.2214	0.61411	1	0.412	0.0909	0.375	0.46919	0.15
MARKS_HDAC_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_HDAC_TARGETS_DN	-0.54997	-1.2708	0.1656	0.61155	1	0.4	0.0517	0.38	0.46777	0.148
WHITFIELD_CELL_CYCLE_G2_M	202	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2_M	-0.39846	-1.2707	0.1702	0.60823	1	0.317	0.106	0.286	0.46522	0.145
SA_G1_AND_S_PHASES	15	http://www.broadinstitute.org/gsea/msigdb/cards/SA_G1_AND_S_PHASES	-0.52446	-1.2676	0.1532	0.61489	1	0.667	0.238	0.508	0.47253	0.15
BIOCARTA_CELLCYCLE_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CELLCYCLE_PATHWAY	-0.50566	-1.2674	0.176	0.61204	1	0.348	0.0517	0.33	0.46964	0.149
TENEDINI_MEGAKARYOCYTE_MARKERS	65	http://www.broadinstitute.org/gsea/msigdb/cards/TENEDINI_MEGAKARYOCYTE_MARKERS	-0.40917	-1.266	0.154	0.61328	1	0.262	0.0908	0.239	0.47003	0.148
REACTOME_G2_M_CHECKPOINTS	40	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G2_M_CHECKPOINTS	-0.53296	-1.2651	0.2374	0.61238	1	0.45	0.121	0.396	0.46836	0.148
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-0.39398	-1.2621	0.167	0.61898	1	0.235	0.0904	0.215	0.47689	0.153
FUKUSHIMA_TNFSF11_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/FUKUSHIMA_TNFSF11_TARGETS	-0.49073	-1.2599	0.204	0.62262	1	0.438	0.143	0.375	0.48381	0.154
KORKOLA_CORRELATED_WITH_POU5F1	33	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_CORRELATED_WITH_POU5F1	-0.45285	-1.2581	0.1434	0.62507	1	0.455	0.189	0.369	0.485	0.157
CUI_TCF21_TARGETS_2_UP	412	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_2_UP	-0.3493	-1.2561	0.1176	0.62822	1	0.306	0.125	0.273	0.48766	0.156
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	108	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	-0.4572	-1.2553	0.2297	0.62758	1	0.454	0.255	0.34	0.48706	0.156
PID_BARD1_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BARD1_PATHWAY	-0.51984	-1.2549	0.2259	0.62509	1	0.345	0.059	0.325	0.48526	0.154
SERVITJA_LIVER_HNF1A_TARGETS_UP	128	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_LIVER_HNF1A_TARGETS_UP	-0.36945	-1.2541	0.1317	0.62418	1	0.281	0.0793	0.261	0.48661	0.154
BURTON_ADIPOGENESIS_4	44	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_4	-0.37093	-1.2535	0.1459	0.62263	1	0.295	0.0957	0.268	0.48518	0.152
LU_TUMOR_VASCULATURE_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_VASCULATURE_UP	-0.55885	-1.2526	0.2041	0.62179	1	0.414	0.0828	0.38	0.48537	0.152
MIKKELSEN_MEF_LCP_WITH_H3K27ME3	60	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_LCP_WITH_H3K27ME3	-0.46401	-1.2522	0.229	0.61958	1	0.383	0.255	0.286	0.48311	0.149
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	66	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	-0.40229	-1.2517	0.1304	0.61788	1	0.242	0.0442	0.232	0.48145	0.147
DUAN_PRDM5_TARGETS	70	http://www.broadinstitute.org/gsea/msigdb/cards/DUAN_PRDM5_TARGETS	-0.37261	-1.2508	0.1621	0.61728	1	0.343	0.127	0.3	0.48166	0.147
SANSOM_APC_TARGETS_REQUIRE_MYC	186	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_REQUIRE_MYC	-0.34456	-1.2487	0.1335	0.62101	1	0.333	0.146	0.287	0.485	0.15
HORIUCHI_WTAP_TARGETS_DN	291	http://www.broadinstitute.org/gsea/msigdb/cards/HORIUCHI_WTAP_TARGETS_DN	-0.44072	-1.2469	0.2153	0.62328	1	0.302	0.0699	0.285	0.48741	0.15
RUIZ_TNC_TARGETS_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/RUIZ_TNC_TARGETS_DN	-0.46106	-1.245	0.2372	0.62603	1	0.398	0.0924	0.364	0.48922	0.151
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	238	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_GLIOBLASTOMA_PLASTICITY_UP	-0.37711	-1.2424	0.1748	0.63117	1	0.315	0.104	0.286	0.49263	0.153
PEART_HDAC_PROLIFERATION_CLUSTER_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/PEART_HDAC_PROLIFERATION_CLUSTER_DN	-0.39573	-1.24	0.1934	0.63564	1	0.311	0.108	0.278	0.49752	0.156
JIANG_TIP30_TARGETS_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_TIP30_TARGETS_DN	-0.47318	-1.2385	0.1842	0.63678	1	0.545	0.251	0.409	0.49807	0.156
PID_ATR_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATR_PATHWAY	-0.46633	-1.2371	0.239	0.63771	1	0.289	0.0599	0.273	0.49997	0.157
MIKKELSEN_ES_ICP_WITH_H3K27ME3	37	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_ICP_WITH_H3K27ME3	-0.4443	-1.2349	0.1886	0.64136	1	0.459	0.254	0.343	0.50518	0.157
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_STEM_CELL_UP	-0.38195	-1.2329	0.1281	0.64465	1	0.422	0.131	0.368	0.50909	0.158
VERRECCHIA_RESPONSE_TO_TGFB1_C5	20	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_RESPONSE_TO_TGFB1_C5	-0.45317	-1.2317	0.2266	0.64521	1	0.35	0.149	0.298	0.5092	0.159
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-0.49052	-1.2243	0.268	0.66667	1	0.375	0.0903	0.342	0.52744	0.177
WILLIAMS_ESR1_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WILLIAMS_ESR1_TARGETS_UP	-0.44218	-1.224	0.2058	0.6644	1	0.423	0.116	0.374	0.527	0.174
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	263	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_LATE_2	-0.41613	-1.2212	0.2447	0.67023	1	0.281	0.0816	0.262	0.53146	0.18
THILLAINADESAN_ZNF217_TARGETS_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/THILLAINADESAN_ZNF217_TARGETS_UP	-0.4424	-1.2203	0.2353	0.6696	1	0.357	0.0846	0.328	0.53157	0.178
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	35	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_8	-0.45634	-1.22	0.2108	0.66721	1	0.314	0.119	0.277	0.52911	0.176
AUNG_GASTRIC_CANCER	51	http://www.broadinstitute.org/gsea/msigdb/cards/AUNG_GASTRIC_CANCER	-0.33609	-1.2189	0.1372	0.66741	1	0.157	0.0534	0.149	0.53163	0.174
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	26	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	-0.48403	-1.2179	0.2136	0.66723	1	0.269	0.123	0.236	0.53154	0.173
PID_E2F_PATHWAY	74	http://www.broadinstitute.org/gsea/msigdb/cards/PID_E2F_PATHWAY	-0.41445	-1.2159	0.2406	0.67018	1	0.243	0.0678	0.228	0.53252	0.176
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	-0.47065	-1.2121	0.2358	0.67978	1	0.4	0.0816	0.368	0.54051	0.185
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	62	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	-0.36764	-1.2115	0.2038	0.67832	1	0.516	0.257	0.384	0.54245	0.181
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	15	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON	-0.52984	-1.2104	0.2593	0.67841	1	0.6	0.282	0.431	0.54126	0.18
ROLEF_GLIS3_TARGETS	37	http://www.broadinstitute.org/gsea/msigdb/cards/ROLEF_GLIS3_TARGETS	-0.39191	-1.2095	0.1534	0.67778	1	0.324	0.119	0.286	0.54141	0.179
BERNARD_PPAPDC1B_TARGETS_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BERNARD_PPAPDC1B_TARGETS_DN	-0.37227	-1.2073	0.1581	0.68149	1	0.309	0.1	0.279	0.54471	0.184
ZHAN_LATE_DIFFERENTIATION_GENES_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_LATE_DIFFERENTIATION_GENES_DN	-0.57068	-1.2059	0.251	0.68284	1	0.333	0.0481	0.318	0.5462	0.184
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	182	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-0.35868	-1.2054	0.165	0.6812	1	0.258	0.0699	0.242	0.5449	0.184
KAUFFMANN_DNA_REPLICATION_GENES	139	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPLICATION_GENES	-0.35616	-1.2047	0.2485	0.68016	1	0.309	0.127	0.272	0.54306	0.183
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	-0.48994	-1.2036	0.2796	0.68063	1	0.525	0.137	0.454	0.54376	0.183
KANG_AR_TARGETS_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_AR_TARGETS_UP	-0.53515	-1.2028	0.2768	0.67983	1	0.471	0.118	0.415	0.54251	0.183
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	34	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	-0.49654	-1.1989	0.2753	0.68955	1	0.471	0.139	0.406	0.55106	0.19
YE_METASTATIC_LIVER_CANCER	25	http://www.broadinstitute.org/gsea/msigdb/cards/YE_METASTATIC_LIVER_CANCER	-0.41764	-1.1981	0.2058	0.6888	1	0.32	0.0976	0.289	0.55067	0.19
KEGG_CELL_CYCLE	122	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CELL_CYCLE	-0.40265	-1.1976	0.2729	0.68717	1	0.254	0.0699	0.238	0.55026	0.189
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-0.49486	-1.1973	0.2826	0.68499	1	0.245	0.0129	0.242	0.54818	0.187
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	-0.40554	-1.1971	0.2505	0.68243	1	0.233	0.0928	0.212	0.54559	0.185
PID_AURORA_B_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AURORA_B_PATHWAY	-0.46379	-1.1949	0.2744	0.68317	1	0.333	0.0598	0.314	0.54837	0.184
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	15	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	-0.42056	-1.1949	0.2544	0.68636	1	0.333	0.227	0.258	0.55096	0.188
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	306	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	-0.40446	-1.1911	0.2619	0.69245	1	0.284	0.0909	0.262	0.55657	0.19
HUANG_GATA2_TARGETS_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_GATA2_TARGETS_DN	-0.35368	-1.1911	0.183	0.68923	1	0.47	0.215	0.37	0.55398	0.189
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	-0.451	-1.191	0.2401	0.68632	1	0.533	0.24	0.405	0.55183	0.186
AIGNER_ZEB1_TARGETS	35	http://www.broadinstitute.org/gsea/msigdb/cards/AIGNER_ZEB1_TARGETS	-0.44662	-1.1893	0.2505	0.68857	1	0.314	0.103	0.282	0.55432	0.187
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	-0.41075	-1.1881	0.2378	0.68935	1	0.226	0.0508	0.215	0.55431	0.188
SU_PLACENTA	29	http://www.broadinstitute.org/gsea/msigdb/cards/SU_PLACENTA	-0.45801	-1.188	0.25	0.68678	1	0.345	0.0936	0.313	0.55281	0.187
PID_FANCONI_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FANCONI_PATHWAY	-0.41703	-1.187	0.261	0.68682	1	0.244	0.0525	0.232	0.55393	0.186
MEISSNER_NPC_HCP_WITH_H3K27ME3	77	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K27ME3	-0.34763	-1.1869	0.2293	0.68397	1	0.338	0.239	0.258	0.55143	0.183
WONG_EMBRYONIC_STEM_CELL_CORE	322	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_EMBRYONIC_STEM_CELL_CORE	-0.41613	-1.1865	0.303	0.68232	1	0.258	0.0824	0.24	0.55066	0.182
REACTOME_GAP_JUNCTION_ASSEMBLY	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GAP_JUNCTION_ASSEMBLY	-0.52885	-1.1864	0.2648	0.67953	1	0.5	0.229	0.386	0.54819	0.178
BIOCARTA_G1_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_G1_PATHWAY	-0.44136	-1.1797	0.2365	0.69749	1	0.321	0.0692	0.3	0.567	0.19
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	21	http://www.broadinstitute.org/gsea/msigdb/cards/WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	-0.44755	-1.1769	0.2544	0.70351	1	0.476	0.241	0.362	0.57441	0.195
HAMAI_APOPTOSIS_VIA_TRAIL_DN	175	http://www.broadinstitute.org/gsea/msigdb/cards/HAMAI_APOPTOSIS_VIA_TRAIL_DN	-0.37567	-1.1762	0.2199	0.70271	1	0.383	0.198	0.31	0.57468	0.194
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	99	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-0.37528	-1.1738	0.2549	0.70715	1	0.232	0.0672	0.218	0.57721	0.197
CHICAS_RB1_TARGETS_LOW_SERUM	89	http://www.broadinstitute.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_LOW_SERUM	-0.37929	-1.1735	0.2618	0.70523	1	0.202	0.0464	0.194	0.57624	0.195
SHEN_SMARCA2_TARGETS_DN	334	http://www.broadinstitute.org/gsea/msigdb/cards/SHEN_SMARCA2_TARGETS_DN	-0.35734	-1.1723	0.2206	0.70581	1	0.506	0.325	0.347	0.57871	0.195
LIU_IL13_MEMORY_MODEL_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_IL13_MEMORY_MODEL_UP	-0.4463	-1.1697	0.248	0.71097	1	0.353	0.148	0.301	0.58373	0.196
YOKOE_CANCER_TESTIS_ANTIGENS	34	http://www.broadinstitute.org/gsea/msigdb/cards/YOKOE_CANCER_TESTIS_ANTIGENS	-0.37831	-1.165	0.215	0.72274	1	0.235	0.0507	0.224	0.59915	0.207
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_ENDOTHELIAL_MARKERS_UP	-0.53752	-1.164	0.2924	0.72263	1	0.364	0.0749	0.337	0.59966	0.209
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	21	http://www.broadinstitute.org/gsea/msigdb/cards/OKAWA_NEUROBLASTOMA_1P36_31_DELETION	-0.43054	-1.1634	0.2758	0.72154	1	0.429	0.241	0.326	0.59868	0.209
POOLA_INVASIVE_BREAST_CANCER_UP	272	http://www.broadinstitute.org/gsea/msigdb/cards/POOLA_INVASIVE_BREAST_CANCER_UP	-0.44789	-1.1611	0.2909	0.72584	1	0.301	0.102	0.274	0.60468	0.21
OLSSON_E2F3_TARGETS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/OLSSON_E2F3_TARGETS_DN	-0.43656	-1.1606	0.3232	0.72425	1	0.326	0.0777	0.301	0.60376	0.21
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	347	http://www.broadinstitute.org/gsea/msigdb/cards/DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	-0.29999	-1.1605	0.215	0.72156	1	0.285	0.143	0.249	0.6012	0.206
KRIGE_AMINO_ACID_DEPRIVATION	27	http://www.broadinstitute.org/gsea/msigdb/cards/KRIGE_AMINO_ACID_DEPRIVATION	-0.46432	-1.1576	0.2947	0.72758	1	0.407	0.148	0.348	0.60442	0.21
BAKER_HEMATOPOIESIS_STAT3_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/BAKER_HEMATOPOIESIS_STAT3_TARGETS	-0.45189	-1.1551	0.2748	0.72962	1	0.375	0.0541	0.355	0.61137	0.212
BHAT_ESR1_TARGETS_VIA_AKT1_UP	269	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_VIA_AKT1_UP	-0.31468	-1.1551	0.1942	0.73265	1	0.353	0.183	0.292	0.61394	0.214
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	-0.467	-1.1534	0.2977	0.73193	1	0.45	0.114	0.399	0.61416	0.213
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	139	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	-0.34815	-1.1532	0.2402	0.7298	1	0.381	0.205	0.305	0.61256	0.212
SPIRA_SMOKERS_LUNG_CANCER_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/SPIRA_SMOKERS_LUNG_CANCER_DN	-0.40757	-1.1514	0.2831	0.73218	1	0.35	0.23	0.27	0.61359	0.213
REACTOME_MEIOTIC_RECOMBINATION	59	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOTIC_RECOMBINATION	-0.40656	-1.1503	0.3006	0.73253	1	0.288	0.12	0.254	0.61362	0.211
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	-0.32443	-1.1489	0.2587	0.73386	1	0.167	0.0811	0.153	0.61504	0.212
WEBER_METHYLATED_IN_COLON_CANCER	18	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_IN_COLON_CANCER	-0.45447	-1.1461	0.3051	0.73985	1	0.278	0.0513	0.264	0.62378	0.219
REACTOME_DNA_REPLICATION	181	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_REPLICATION	-0.3906	-1.1457	0.3426	0.73803	1	0.265	0.0903	0.243	0.62317	0.218
NAKAYAMA_FGF2_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_FGF2_TARGETS	-0.43883	-1.1422	0.3027	0.74627	1	0.357	0.128	0.312	0.6277	0.221
KEGG_ONE_CARBON_POOL_BY_FOLATE	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ONE_CARBON_POOL_BY_FOLATE	-0.45875	-1.1381	0.3166	0.75637	1	0.312	0.0937	0.283	0.63927	0.228
PUJANA_BRCA2_PCC_NETWORK	408	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BRCA2_PCC_NETWORK	-0.3908	-1.1377	0.3353	0.75442	1	0.26	0.0793	0.244	0.63821	0.226
REACTOME_TELOMERE_MAINTENANCE	59	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TELOMERE_MAINTENANCE	-0.38908	-1.1368	0.3287	0.75418	1	0.424	0.221	0.331	0.63783	0.226
PUJANA_XPRSS_INT_NETWORK	164	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_XPRSS_INT_NETWORK	-0.42067	-1.1365	0.3517	0.75223	1	0.299	0.0781	0.278	0.63708	0.226
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP	-0.43117	-1.1326	0.2829	0.76167	1	0.368	0.0627	0.346	0.64391	0.229
KORKOLA_TERATOMA	38	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_TERATOMA	-0.3976	-1.1324	0.2984	0.75938	1	0.263	0.0393	0.253	0.64296	0.228
REACTOME_FANCONI_ANEMIA_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FANCONI_ANEMIA_PATHWAY	-0.45233	-1.1321	0.3289	0.75738	1	0.333	0.0771	0.308	0.64196	0.227
PIONTEK_PKD1_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/PIONTEK_PKD1_TARGETS_DN	-0.41537	-1.1304	0.2919	0.75965	1	0.125	0.00765	0.124	0.6447	0.228
JACKSON_DNMT1_TARGETS_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/JACKSON_DNMT1_TARGETS_DN	-0.42279	-1.129	0.2823	0.76122	1	0.409	0.152	0.347	0.64643	0.227
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	127	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	-0.35752	-1.1281	0.2764	0.76107	1	0.291	0.0655	0.274	0.64678	0.227
LY_AGING_OLD_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_OLD_DN	-0.45253	-1.1277	0.3652	0.75933	1	0.309	0.0655	0.29	0.64684	0.227
KEGG_TASTE_TRANSDUCTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TASTE_TRANSDUCTION	-0.33967	-1.1275	0.2819	0.75686	1	0.136	0.0734	0.127	0.64434	0.227
CHEN_HOXA5_TARGETS_9HR_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_HOXA5_TARGETS_9HR_DN	-0.42274	-1.1266	0.3209	0.7567	1	0.486	0.225	0.378	0.64331	0.226
GENTILE_UV_HIGH_DOSE_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_HIGH_DOSE_UP	-0.46786	-1.1249	0.336	0.75911	1	0.364	0.13	0.317	0.64633	0.227
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	31	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	-0.37862	-1.1225	0.2621	0.76386	1	0.258	0.0676	0.241	0.65194	0.23
BIOCARTA_ATRBRCA_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ATRBRCA_PATHWAY	-0.46291	-1.121	0.3392	0.76547	1	0.35	0.059	0.33	0.65353	0.231
YANG_BREAST_CANCER_ESR1_BULK_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_BULK_DN	-0.40131	-1.1201	0.3046	0.76542	1	0.227	0.0174	0.224	0.65157	0.231
REACTOME_MITOTIC_M_M_G1_PHASES	161	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_M_M_G1_PHASES	-0.38384	-1.12	0.3491	0.7629	1	0.267	0.0903	0.245	0.64968	0.23
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	295	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	-0.32346	-1.1189	0.2616	0.7635	1	0.308	0.112	0.278	0.65213	0.23
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	-0.46998	-1.1175	0.3353	0.76507	1	0.391	0.165	0.327	0.65291	0.23
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-0.29327	-1.1174	0.266	0.76235	1	0.384	0.184	0.315	0.65084	0.229
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	67	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP	-0.29995	-1.1159	0.2377	0.76413	1	0.179	0.0643	0.168	0.65221	0.229
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	-0.42146	-1.114	0.2966	0.76721	1	0.333	0.0635	0.312	0.65552	0.231
MURATA_VIRULENCE_OF_H_PILORI	24	http://www.broadinstitute.org/gsea/msigdb/cards/MURATA_VIRULENCE_OF_H_PILORI	-0.44576	-1.112	0.3208	0.77044	1	0.208	0.044	0.199	0.65805	0.234
MIKKELSEN_IPS_LCP_WITH_H3K4ME3	148	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_LCP_WITH_H3K4ME3	-0.333	-1.1109	0.3293	0.77116	1	0.351	0.221	0.276	0.65877	0.236
REACTOME_AMINE_DERIVED_HORMONES	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINE_DERIVED_HORMONES	-0.4833	-1.1108	0.3359	0.76877	1	0.6	0.392	0.365	0.65635	0.232
REACTOME_CELL_CYCLE	372	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE	-0.34813	-1.1099	0.3504	0.76892	1	0.247	0.0993	0.227	0.65672	0.234
GOLDRATH_ANTIGEN_RESPONSE	329	http://www.broadinstitute.org/gsea/msigdb/cards/GOLDRATH_ANTIGEN_RESPONSE	-0.34625	-1.1098	0.324	0.76649	1	0.243	0.0887	0.225	0.65514	0.232
PUJANA_BRCA_CENTERED_NETWORK	117	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BRCA_CENTERED_NETWORK	-0.4177	-1.1094	0.3795	0.76497	1	0.299	0.0781	0.277	0.65524	0.228
PRAMOONJAGO_SOX4_TARGETS_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/PRAMOONJAGO_SOX4_TARGETS_DN	-0.35439	-1.1093	0.3186	0.76247	1	0.204	0.0696	0.19	0.65373	0.227
MOREIRA_RESPONSE_TO_TSA_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_DN	-0.4039	-1.1088	0.3092	0.76124	1	0.278	0.0843	0.255	0.65297	0.225
WEIGEL_OXIDATIVE_STRESS_RESPONSE	33	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_RESPONSE	-0.36739	-1.1079	0.3167	0.76109	1	0.212	0.0571	0.2	0.65373	0.223
CAFFAREL_RESPONSE_TO_THC_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_DN	-0.43486	-1.107	0.3398	0.76107	1	0.444	0.136	0.385	0.65333	0.222
SCIBETTA_KDM5B_TARGETS_DN	77	http://www.broadinstitute.org/gsea/msigdb/cards/SCIBETTA_KDM5B_TARGETS_DN	-0.40256	-1.1059	0.3528	0.76174	1	0.312	0.0694	0.291	0.6542	0.223
REACTOME_CHROMOSOME_MAINTENANCE	100	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHROMOSOME_MAINTENANCE	-0.35817	-1.1056	0.3495	0.75991	1	0.25	0.095	0.227	0.65309	0.217
KIM_ALL_DISORDERS_CALB1_CORR_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_CALB1_CORR_DN	-0.37046	-1.1056	0.2883	0.75724	1	0.324	0.23	0.249	0.65079	0.215
WELCSH_BRCA1_TARGETS_DN	136	http://www.broadinstitute.org/gsea/msigdb/cards/WELCSH_BRCA1_TARGETS_DN	-0.29667	-1.1018	0.3048	0.76599	1	0.382	0.226	0.298	0.65865	0.228
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	457	http://www.broadinstitute.org/gsea/msigdb/cards/SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	-0.26759	-1.1012	0.3109	0.76532	1	0.234	0.124	0.21	0.65992	0.224
ROVERSI_GLIOMA_COPY_NUMBER_UP	93	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_COPY_NUMBER_UP	-0.31731	-1.1007	0.334	0.76399	1	0.538	0.299	0.379	0.65869	0.219
RHODES_CANCER_META_SIGNATURE	63	http://www.broadinstitute.org/gsea/msigdb/cards/RHODES_CANCER_META_SIGNATURE	-0.41707	-1.0991	0.4	0.76602	1	0.19	0.0541	0.181	0.66186	0.225
REACTOME_CELL_CYCLE_MITOTIC	298	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE_MITOTIC	-0.35879	-1.099	0.3649	0.7638	1	0.245	0.093	0.225	0.65956	0.217
WEST_ADRENOCORTICAL_TUMOR_UP	281	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_UP	-0.36574	-1.0989	0.3666	0.76151	1	0.235	0.0891	0.217	0.65732	0.216
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	-0.33417	-1.0988	0.2945	0.75918	1	0.212	0.0834	0.195	0.65505	0.215
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	-0.41507	-1.0979	0.3426	0.75928	1	0.562	0.209	0.445	0.65437	0.215
YIH_RESPONSE_TO_ARSENITE_C3	34	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C3	-0.37808	-1.0968	0.3467	0.75986	1	0.324	0.0934	0.294	0.65611	0.215
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	30	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.37076	-1.0961	0.371	0.75937	1	0.433	0.177	0.357	0.65638	0.215
GAL_LEUKEMIC_STEM_CELL_DN	237	http://www.broadinstitute.org/gsea/msigdb/cards/GAL_LEUKEMIC_STEM_CELL_DN	-0.33966	-1.0949	0.3282	0.7604	1	0.266	0.0978	0.243	0.65809	0.215
OUYANG_PROSTATE_CANCER_MARKERS	19	http://www.broadinstitute.org/gsea/msigdb/cards/OUYANG_PROSTATE_CANCER_MARKERS	-0.42103	-1.0935	0.3288	0.76192	1	0.263	0.0718	0.245	0.66074	0.216
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	-0.40368	-1.0933	0.3361	0.75983	1	0.348	0.137	0.301	0.65903	0.214
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	48	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	-0.42771	-1.0932	0.3373	0.75774	1	0.333	0.106	0.299	0.65721	0.214
PEDRIOLI_MIR31_TARGETS_UP	189	http://www.broadinstitute.org/gsea/msigdb/cards/PEDRIOLI_MIR31_TARGETS_UP	-0.28786	-1.0917	0.2778	0.75955	1	0.328	0.176	0.273	0.65875	0.213
VIETOR_IFRD1_TARGETS	21	http://www.broadinstitute.org/gsea/msigdb/cards/VIETOR_IFRD1_TARGETS	-0.41677	-1.091	0.3313	0.75888	1	0.333	0.0831	0.306	0.65874	0.213
MUELLER_METHYLATED_IN_GLIOBLASTOMA	38	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_METHYLATED_IN_GLIOBLASTOMA	-0.41814	-1.0889	0.3589	0.76263	1	0.342	0.129	0.298	0.66346	0.214
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	-0.42455	-1.0884	0.3612	0.76179	1	0.348	0.0716	0.323	0.66271	0.214
TOMIDA_METASTASIS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/TOMIDA_METASTASIS_UP	-0.37521	-1.0858	0.3781	0.76664	1	0.125	0.00755	0.124	0.66884	0.221
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	-0.35027	-1.0845	0.3063	0.76797	1	0.4	0.139	0.345	0.6694	0.221
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	-0.33488	-1.0829	0.3347	0.76752	1	0.277	0.148	0.236	0.66845	0.221
WHITFIELD_CELL_CYCLE_G1_S	130	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G1_S	-0.35169	-1.0829	0.3813	0.76998	1	0.231	0.0692	0.216	0.67065	0.223
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	-0.38223	-1.0809	0.3478	0.77082	1	0.545	0.233	0.419	0.67126	0.223
PID_RHODOPSIN_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHODOPSIN_PATHWAY	-0.35327	-1.0805	0.3393	0.76944	1	0.5	0.359	0.321	0.67072	0.222
PID_P73PATHWAY	76	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P73PATHWAY	-0.32815	-1.0791	0.3359	0.77084	1	0.263	0.102	0.237	0.6709	0.225
REACTOME_AMYLOIDS	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMYLOIDS	-0.40151	-1.0788	0.3653	0.76928	1	0.464	0.255	0.347	0.66942	0.223
LIAO_HAVE_SOX4_BINDING_SITES	40	http://www.broadinstitute.org/gsea/msigdb/cards/LIAO_HAVE_SOX4_BINDING_SITES	-0.34424	-1.0776	0.3213	0.77043	1	0.35	0.0896	0.319	0.6724	0.223
REACTOME_PACKAGING_OF_TELOMERE_ENDS	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PACKAGING_OF_TELOMERE_ENDS	-0.42815	-1.0772	0.416	0.76921	1	0.424	0.208	0.336	0.67024	0.221
LI_WILMS_TUMOR	24	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR	-0.41117	-1.0763	0.3602	0.76917	1	0.417	0.0819	0.383	0.67368	0.221
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	-0.34242	-1.0755	0.3347	0.76884	1	0.22	0.0557	0.21	0.67179	0.22
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	75	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	-0.34761	-1.0752	0.3468	0.76721	1	0.213	0.0571	0.202	0.67007	0.217
GRADE_COLON_VS_RECTAL_CANCER_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_VS_RECTAL_CANCER_DN	-0.29881	-1.0706	0.3161	0.778	1	0.265	0.112	0.236	0.68112	0.225
SMID_BREAST_CANCER_ERBB2_UP	139	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_ERBB2_UP	-0.30315	-1.0702	0.3195	0.77677	1	0.353	0.182	0.29	0.68103	0.224
BENPORATH_ES_1	356	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_1	-0.3385	-1.0696	0.3673	0.77612	1	0.278	0.0994	0.255	0.68108	0.224
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	-0.32314	-1.0681	0.3624	0.77803	1	0.319	0.139	0.275	0.68539	0.226
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	206	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	-0.29046	-1.0611	0.3445	0.79592	1	0.35	0.178	0.29	0.70128	0.243
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	-0.35187	-1.0609	0.3709	0.79387	1	0.375	0.154	0.319	0.6992	0.24
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	-0.37303	-1.0605	0.4074	0.7927	1	0.647	0.343	0.425	0.69984	0.237
MUELLER_PLURINET	282	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_PLURINET	-0.3232	-1.0598	0.3984	0.79222	1	0.27	0.139	0.235	0.69819	0.236
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	34	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_7P22_AMPLICON	-0.39549	-1.0584	0.428	0.79379	1	0.5	0.268	0.367	0.7	0.238
LU_EZH2_TARGETS_UP	250	http://www.broadinstitute.org/gsea/msigdb/cards/LU_EZH2_TARGETS_UP	-0.30824	-1.0577	0.3705	0.79338	1	0.388	0.216	0.308	0.6996	0.238
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	33	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	-0.36845	-1.0565	0.3815	0.79431	1	0.152	0.122	0.133	0.70188	0.24
PID_ARF_3PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF_3PATHWAY	-0.37477	-1.056	0.4008	0.79312	1	0.316	0.0914	0.287	0.69998	0.236
BORLAK_LIVER_CANCER_EGF_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/BORLAK_LIVER_CANCER_EGF_UP	-0.35491	-1.0541	0.3574	0.79629	1	0.259	0.0926	0.236	0.70372	0.24
GHO_ATF5_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/GHO_ATF5_TARGETS_DN	-0.42911	-1.0533	0.4049	0.79623	1	0.188	0.0137	0.185	0.70402	0.24
MODY_HIPPOCAMPUS_PRENATAL	37	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_PRENATAL	-0.36208	-1.0528	0.3975	0.79523	1	0.189	0.0601	0.178	0.70407	0.239
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	-0.38524	-1.0527	0.4338	0.79302	1	0.317	0.158	0.268	0.70193	0.238
REACTOME_OLFACTORY_SIGNALING_PATHWAY	74	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OLFACTORY_SIGNALING_PATHWAY	-0.31761	-1.0517	0.4274	0.79351	1	0.351	0.412	0.207	0.70304	0.237
SEMENZA_HIF1_TARGETS	34	http://www.broadinstitute.org/gsea/msigdb/cards/SEMENZA_HIF1_TARGETS	-0.38768	-1.0508	0.4227	0.79375	1	0.235	0.0834	0.216	0.70396	0.236
MARKEY_RB1_CHRONIC_LOF_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_CHRONIC_LOF_UP	-0.30279	-1.0503	0.3818	0.79257	1	0.185	0.0461	0.178	0.70297	0.236
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	-0.33228	-1.0503	0.3866	0.79029	1	0.342	0.142	0.294	0.70087	0.234
NIELSEN_LEIOMYOSARCOMA_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_UP	-0.43081	-1.0478	0.3727	0.79483	1	0.412	0.173	0.341	0.70565	0.239
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	83	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	-0.30148	-1.0453	0.3901	0.79952	1	0.349	0.286	0.251	0.71151	0.241
REACTOME_GLYCOLYSIS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOLYSIS	-0.35275	-1.0448	0.42	0.79842	1	0.269	0.123	0.236	0.71018	0.24
KIM_TIAL1_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_TIAL1_TARGETS	-0.34093	-1.0433	0.3825	0.80019	1	0.286	0.0937	0.259	0.71256	0.244
DORN_ADENOVIRUS_INFECTION_12HR_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_12HR_DN	-0.37413	-1.0431	0.4156	0.79844	1	0.258	0.0517	0.245	0.71123	0.242
MATZUK_IMPLANTATION_AND_UTERINE	21	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_IMPLANTATION_AND_UTERINE	-0.37918	-1.0423	0.3978	0.79851	1	0.286	0.048	0.272	0.71112	0.24
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	-0.37102	-1.0422	0.4004	0.79636	1	0.37	0.238	0.283	0.70912	0.237
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	26	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	-0.34839	-1.0415	0.398	0.79362	1	0.346	0.279	0.25	0.70716	0.232
HU_GENOTOXIC_DAMAGE_24HR	31	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_24HR	-0.34594	-1.0415	0.3752	0.79593	1	0.226	0.0474	0.215	0.70923	0.236
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	-0.37285	-1.0384	0.393	0.80005	1	0.25	0.058	0.236	0.71472	0.24
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	53	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	-0.33926	-1.0382	0.3916	0.79833	1	0.358	0.161	0.301	0.71368	0.238
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	-0.31207	-1.038	0.3823	0.79658	1	0.474	0.216	0.372	0.71182	0.237
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	-0.28669	-1.0337	0.4004	0.80597	1	0.286	0.156	0.242	0.72229	0.248
SASAKI_ADULT_T_CELL_LEUKEMIA	167	http://www.broadinstitute.org/gsea/msigdb/cards/SASAKI_ADULT_T_CELL_LEUKEMIA	-0.328	-1.0331	0.4247	0.80558	1	0.21	0.0594	0.199	0.72257	0.246
KEGG_P53_SIGNALING_PATHWAY	65	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_P53_SIGNALING_PATHWAY	-0.34266	-1.033	0.3976	0.80335	1	0.215	0.059	0.203	0.7205	0.243
MIKKELSEN_ES_LCP_WITH_H3K4ME3	119	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_LCP_WITH_H3K4ME3	-0.32494	-1.0329	0.4213	0.80129	1	0.353	0.221	0.277	0.71882	0.24
NABA_COLLAGENS	44	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_COLLAGENS	-0.42194	-1.0326	0.4204	0.7999	1	0.432	0.114	0.384	0.71704	0.238
MACLACHLAN_BRCA1_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MACLACHLAN_BRCA1_TARGETS_DN	-0.39229	-1.0302	0.372	0.8041	1	0.312	0.0988	0.282	0.72203	0.242
BIOCARTA_BARRESTIN_SRC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BARRESTIN_SRC_PATHWAY	-0.36564	-1.0297	0.4065	0.80335	1	0.133	0.00755	0.132	0.72233	0.242
RICKMAN_METASTASIS_DN	245	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_METASTASIS_DN	-0.29611	-1.0287	0.4088	0.80387	1	0.412	0.219	0.326	0.72462	0.242
MOREIRA_RESPONSE_TO_TSA_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_UP	-0.36501	-1.0287	0.4316	0.80164	1	0.36	0.172	0.299	0.72258	0.239
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	138	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	-0.3321	-1.0276	0.4142	0.80225	1	0.442	0.231	0.342	0.72294	0.241
MURAKAMI_UV_RESPONSE_6HR_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_6HR_DN	-0.39141	-1.0263	0.4391	0.80371	1	0.35	0.151	0.298	0.72534	0.242
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	-0.29355	-1.0259	0.4186	0.8023	1	0.212	0.0691	0.198	0.72376	0.24
HARRIS_HYPOXIA	78	http://www.broadinstitute.org/gsea/msigdb/cards/HARRIS_HYPOXIA	-0.34687	-1.0252	0.4469	0.80194	1	0.205	0.067	0.192	0.72292	0.239
SANSOM_APC_TARGETS_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_UP	-0.29115	-1.0244	0.3881	0.80201	1	0.286	0.133	0.249	0.72502	0.239
LABBE_WNT3A_TARGETS_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_WNT3A_TARGETS_UP	-0.30631	-1.0231	0.432	0.80325	1	0.208	0.0845	0.191	0.72563	0.242
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	-0.27336	-1.0224	0.4076	0.80293	1	0.2	0.106	0.179	0.7246	0.241
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	-0.33196	-1.0221	0.4253	0.80125	1	0.243	0.0716	0.226	0.72287	0.239
TSENG_ADIPOGENIC_POTENTIAL_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_ADIPOGENIC_POTENTIAL_UP	-0.35468	-1.0203	0.4064	0.80391	1	0.296	0.0728	0.275	0.72668	0.241
MAHADEVAN_RESPONSE_TO_MP470_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_RESPONSE_TO_MP470_UP	-0.50967	-1.0196	0.4743	0.80376	1	0.316	0.15	0.269	0.72686	0.24
VALK_AML_WITH_11Q23_REARRANGED	19	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_11Q23_REARRANGED	-0.37998	-1.0189	0.4498	0.8034	1	0.316	0.162	0.265	0.7262	0.24
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	-0.36851	-1.0178	0.4422	0.80411	1	0.286	0.0522	0.271	0.72771	0.24
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	-0.33251	-1.0178	0.4449	0.80209	1	0.206	0.0642	0.193	0.72573	0.238
NIELSEN_LIPOSARCOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LIPOSARCOMA_DN	-0.39179	-1.0172	0.4333	0.80156	1	0.421	0.155	0.356	0.72682	0.235
KAMMINGA_SENESCENCE	39	http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_SENESCENCE	-0.30025	-1.0166	0.4258	0.80104	1	0.205	0.0985	0.185	0.72584	0.235
WILCOX_RESPONSE_TO_PROGESTERONE_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/WILCOX_RESPONSE_TO_PROGESTERONE_UP	-0.35728	-1.0135	0.4669	0.80513	1	0.234	0.0509	0.224	0.73076	0.241
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	-0.29488	-1.0135	0.4482	0.80726	1	0.338	0.165	0.283	0.73273	0.242
KEGG_ECM_RECEPTOR_INTERACTION	81	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ECM_RECEPTOR_INTERACTION	-0.35983	-1.0133	0.4322	0.80331	1	0.346	0.103	0.311	0.72891	0.238
DARWICHE_SKIN_TUMOR_PROMOTER_UP	127	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SKIN_TUMOR_PROMOTER_UP	-0.24631	-1.0116	0.4073	0.80597	1	0.252	0.132	0.22	0.73267	0.24
PENG_GLUCOSE_DEPRIVATION_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUCOSE_DEPRIVATION_UP	-0.31508	-1.0111	0.4353	0.80509	1	0.386	0.214	0.304	0.73139	0.24
LEE_LIVER_CANCER_MYC_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_UP	-0.29876	-1.0085	0.4314	0.80994	1	0.122	0.0307	0.119	0.73417	0.242
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	-0.3269	-1.0079	0.4214	0.80931	1	0.391	0.166	0.327	0.73429	0.241
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	421	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	-0.26993	-1.0064	0.4143	0.81135	1	0.344	0.168	0.292	0.73696	0.242
BROWNE_HCMV_INFECTION_2HR_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_2HR_DN	-0.33838	-1.0018	0.4322	0.82156	1	0.188	0.0283	0.183	0.74921	0.255
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-0.3488	-1.0007	0.4464	0.82218	1	0.422	0.138	0.365	0.74915	0.255
PID_MYC_ACTIV_PATHWAY	75	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MYC_ACTIV_PATHWAY	-0.31577	-0.99966	0.4606	0.82277	1	0.227	0.096	0.206	0.74898	0.256
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	99	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-0.28894	-0.99901	0.4629	0.82235	1	0.343	0.168	0.287	0.74901	0.255
KARAKAS_TGFB1_SIGNALING	18	http://www.broadinstitute.org/gsea/msigdb/cards/KARAKAS_TGFB1_SIGNALING	-0.42011	-0.99815	0.4317	0.82262	1	0.278	0.0929	0.252	0.74946	0.254
CHIN_BREAST_CANCER_COPY_NUMBER_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/CHIN_BREAST_CANCER_COPY_NUMBER_UP	-0.40619	-0.99804	0.4891	0.82078	1	0.231	0.0603	0.217	0.74876	0.253
KEGG_PRIMARY_IMMUNODEFICIENCY	35	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PRIMARY_IMMUNODEFICIENCY	-0.38712	-0.99536	0.468	0.82577	1	0.714	0.374	0.448	0.75352	0.257
REACTOME_REGULATION_OF_IFNA_SIGNALING	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_IFNA_SIGNALING	-0.34003	-0.99457	0.4686	0.82564	1	0.304	0.205	0.242	0.75476	0.256
REACTOME_EXTENSION_OF_TELOMERES	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EXTENSION_OF_TELOMERES	-0.35036	-0.99118	0.4594	0.83261	1	0.423	0.221	0.33	0.76211	0.259
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	-0.34458	-0.98965	0.4775	0.8345	1	0.192	0.066	0.18	0.76466	0.259
SANSOM_APC_MYC_TARGETS	197	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_MYC_TARGETS	-0.25172	-0.98754	0.4729	0.83818	1	0.294	0.155	0.251	0.76856	0.262
SABATES_COLORECTAL_ADENOMA_UP	129	http://www.broadinstitute.org/gsea/msigdb/cards/SABATES_COLORECTAL_ADENOMA_UP	-0.32487	-0.98725	0.4872	0.83683	1	0.271	0.122	0.24	0.76777	0.26
DOANE_BREAST_CANCER_ESR1_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_ESR1_DN	-0.34293	-0.98703	0.4922	0.83529	1	0.283	0.109	0.252	0.76674	0.258
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	45	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	-0.27762	-0.98701	0.4598	0.8332	1	0.289	0.137	0.25	0.76478	0.258
REACTOME_MITOTIC_G2_G2_M_PHASES	77	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_G2_G2_M_PHASES	-0.30087	-0.98633	0.485	0.8329	1	0.234	0.112	0.208	0.7652	0.258
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	65	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	-0.27768	-0.98625	0.4854	0.831	1	0.185	0.124	0.162	0.76326	0.258
MODY_HIPPOCAMPUS_NEONATAL	33	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_NEONATAL	-0.35323	-0.98463	0.4682	0.83308	1	0.333	0.127	0.292	0.76589	0.258
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	-0.3657	-0.98452	0.4912	0.83128	1	0.4	0.081	0.368	0.76417	0.258
KEGG_HOMOLOGOUS_RECOMBINATION	28	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HOMOLOGOUS_RECOMBINATION	-0.29706	-0.98421	0.4839	0.83001	1	0.214	0.0956	0.194	0.76225	0.256
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	-0.38095	-0.98285	0.5208	0.83147	1	0.25	0.082	0.23	0.76501	0.255
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	-0.41941	-0.98137	0.5301	0.8334	1	0.222	0.0133	0.219	0.76735	0.256
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	40	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_HBZ	-0.31188	-0.98051	0.4731	0.83351	1	0.25	0.104	0.225	0.76772	0.256
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHORYLATION_OF_THE_APC_C	-0.40627	-0.98032	0.5304	0.83195	1	0.188	0.00466	0.187	0.76593	0.256
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	125	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-0.32573	-0.97991	0.4821	0.83101	1	0.256	0.0828	0.236	0.76503	0.254
CHICAS_RB1_TARGETS_GROWING	232	http://www.broadinstitute.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_GROWING	-0.3411	-0.97675	0.4872	0.83708	1	0.28	0.0676	0.264	0.77326	0.258
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	-0.39322	-0.97608	0.5038	0.8368	1	0.233	0.0253	0.228	0.77327	0.258
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	115	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	-0.26961	-0.97303	0.5306	0.84273	1	0.183	0.106	0.164	0.7813	0.262
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	96	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.29869	-0.9725	0.4832	0.84214	1	0.271	0.155	0.23	0.77979	0.262
PENG_RAPAMYCIN_RESPONSE_UP	192	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_RAPAMYCIN_RESPONSE_UP	-0.24084	-0.97241	0.502	0.84029	1	0.224	0.133	0.196	0.77788	0.26
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	-0.36129	-0.97192	0.4871	0.83958	1	0.241	0.0591	0.227	0.77703	0.259
KORKOLA_YOLK_SAC_TUMOR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_YOLK_SAC_TUMOR_UP	-0.32075	-0.97169	0.493	0.8381	1	0.389	0.134	0.337	0.77609	0.258
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	-0.42938	-0.97015	0.5449	0.84011	1	0.2	0.0133	0.198	0.77996	0.257
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	276	http://www.broadinstitute.org/gsea/msigdb/cards/DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	-0.2391	-0.96988	0.506	0.83878	1	0.333	0.185	0.275	0.77845	0.257
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK	-0.39081	-0.96928	0.501	0.8383	1	0.667	0.283	0.478	0.77861	0.257
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	34	http://www.broadinstitute.org/gsea/msigdb/cards/MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	-0.33713	-0.96902	0.5218	0.83692	1	0.265	0.069	0.247	0.77782	0.255
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	-0.37798	-0.96898	0.5411	0.83502	1	0.316	0.158	0.266	0.77594	0.253
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	37	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	-0.30745	-0.96868	0.4885	0.83379	1	0.297	0.0967	0.269	0.77484	0.252
CROMER_METASTASIS_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_METASTASIS_DN	-0.28448	-0.96781	0.501	0.83409	1	0.449	0.197	0.362	0.77667	0.251
BILD_MYC_ONCOGENIC_SIGNATURE	188	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_MYC_ONCOGENIC_SIGNATURE	-0.26201	-0.96775	0.5094	0.83225	1	0.282	0.146	0.243	0.77481	0.25
PID_RHOA_REG_PATHWAY	44	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHOA_REG_PATHWAY	-0.29292	-0.96726	0.466	0.83154	1	0.409	0.178	0.337	0.77359	0.248
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	31	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS	-0.30632	-0.96676	0.4834	0.83087	1	0.161	0.0514	0.153	0.77435	0.249
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	-0.37773	-0.96674	0.5082	0.82895	1	0.25	0.113	0.222	0.77253	0.247
KANNAN_TP53_TARGETS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/KANNAN_TP53_TARGETS_DN	-0.34265	-0.96513	0.5376	0.83115	1	0.3	0.084	0.275	0.7736	0.249
YUAN_ZNF143_PARTNERS	21	http://www.broadinstitute.org/gsea/msigdb/cards/YUAN_ZNF143_PARTNERS	-0.31736	-0.96027	0.5152	0.84171	1	0.286	0.149	0.244	0.78556	0.255
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.273	-0.95992	0.5117	0.84061	1	0.282	0.138	0.244	0.7856	0.255
VANTVEER_BREAST_CANCER_ESR1_DN	224	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_ESR1_DN	-0.3016	-0.95895	0.499	0.84116	1	0.254	0.107	0.23	0.78626	0.255
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	241	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K27ME3	-0.29811	-0.95881	0.543	0.83951	1	0.419	0.282	0.305	0.78497	0.255
BHATTACHARYA_EMBRYONIC_STEM_CELL	83	http://www.broadinstitute.org/gsea/msigdb/cards/BHATTACHARYA_EMBRYONIC_STEM_CELL	-0.34151	-0.95862	0.5061	0.83804	1	0.205	0.0642	0.192	0.78378	0.255
PID_TAP63_PATHWAY	53	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TAP63_PATHWAY	-0.29104	-0.95818	0.503	0.8372	1	0.226	0.106	0.203	0.78337	0.254
REACTOME_DEFENSINS	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEFENSINS	-0.37508	-0.95758	0.519	0.83678	1	0.13	0.0303	0.127	0.78413	0.254
RAMASWAMY_METASTASIS_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/RAMASWAMY_METASTASIS_UP	-0.28968	-0.95452	0.5168	0.84265	1	0.188	0.109	0.167	0.78909	0.256
REACTOME_SIGNALLING_TO_RAS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_RAS	-0.36945	-0.95316	0.5178	0.84419	1	0.556	0.266	0.409	0.79156	0.255
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	-0.28757	-0.95291	0.5148	0.84284	1	0.233	0.0717	0.216	0.79063	0.255
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	-0.28972	-0.95165	0.5466	0.84404	1	0.184	0.0737	0.171	0.791	0.256
XU_CREBBP_TARGETS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/XU_CREBBP_TARGETS_UP	-0.33603	-0.9514	0.5182	0.84274	1	0.227	0.0564	0.215	0.78943	0.255
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/MARSHALL_VIRAL_INFECTION_RESPONSE_DN	-0.30395	-0.95044	0.5143	0.84333	1	0.276	0.147	0.236	0.7907	0.255
MIKKELSEN_IPS_ICP_WITH_H3K27ME3	47	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_ICP_WITH_H3K27ME3	-0.27855	-0.95033	0.5754	0.84168	1	0.106	0.0334	0.103	0.78935	0.255
HELLER_SILENCED_BY_METHYLATION_UP	265	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_SILENCED_BY_METHYLATION_UP	-0.28982	-0.95004	0.5294	0.84048	1	0.242	0.125	0.214	0.78773	0.255
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-0.37	-0.94984	0.5312	0.83903	1	0.228	0.0504	0.218	0.78662	0.253
LIU_CDX2_TARGETS_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_CDX2_TARGETS_UP	-0.33604	-0.94978	0.5311	0.83727	1	0.286	0.13	0.249	0.78514	0.252
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	-0.31416	-0.94929	0.5397	0.83662	1	0.312	0.14	0.269	0.78492	0.251
ZHANG_PROLIFERATING_VS_QUIESCENT	49	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_PROLIFERATING_VS_QUIESCENT	-0.28454	-0.94868	0.5556	0.83626	1	0.184	0.0586	0.173	0.78516	0.251
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	24	http://www.broadinstitute.org/gsea/msigdb/cards/GAZIN_EPIGENETIC_SILENCING_BY_KRAS	-0.29945	-0.94859	0.5039	0.83458	1	0.292	0.0972	0.264	0.78338	0.25
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	19	http://www.broadinstitute.org/gsea/msigdb/cards/DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	-0.34632	-0.94844	0.5216	0.83303	1	0.316	0.0973	0.285	0.78167	0.247
PID_ATM_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATM_PATHWAY	-0.35435	-0.94737	0.5372	0.83391	1	0.206	0.0525	0.195	0.78324	0.248
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	417	http://www.broadinstitute.org/gsea/msigdb/cards/TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	-0.28904	-0.94636	0.5263	0.83458	1	0.211	0.0937	0.195	0.78437	0.25
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	133	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	-0.32777	-0.94519	0.5354	0.83565	1	0.278	0.108	0.25	0.78513	0.25
LOPES_METHYLATED_IN_COLON_CANCER_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/LOPES_METHYLATED_IN_COLON_CANCER_DN	-0.3178	-0.94496	0.578	0.83437	1	0.214	0.0494	0.204	0.7838	0.248
RASHI_RESPONSE_TO_IONIZING_RADIATION_3	46	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_3	-0.25826	-0.94216	0.5286	0.83948	1	0.348	0.184	0.285	0.78941	0.251
FOSTER_KDM1A_TARGETS_DN	198	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_KDM1A_TARGETS_DN	-0.23883	-0.94205	0.5575	0.83786	1	0.333	0.203	0.268	0.78813	0.25
REACTOME_NCAM1_INTERACTIONS	39	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NCAM1_INTERACTIONS	-0.37703	-0.94155	0.5253	0.83724	1	0.333	0.104	0.299	0.78803	0.249
ODONNELL_METASTASIS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_METASTASIS_DN	-0.35671	-0.94099	0.5371	0.83679	1	0.417	0.133	0.362	0.78781	0.249
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	-0.30432	-0.93942	0.5605	0.83873	1	0.318	0.117	0.281	0.79077	0.249
HUPER_BREAST_BASAL_VS_LUMINAL_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/HUPER_BREAST_BASAL_VS_LUMINAL_DN	-0.30618	-0.93835	0.5768	0.83955	1	0.339	0.129	0.296	0.7923	0.249
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	-0.30813	-0.93822	0.5299	0.83803	1	0.293	0.119	0.258	0.79125	0.249
LI_AMPLIFIED_IN_LUNG_CANCER	168	http://www.broadinstitute.org/gsea/msigdb/cards/LI_AMPLIFIED_IN_LUNG_CANCER	-0.25226	-0.93807	0.5197	0.83653	1	0.208	0.12	0.185	0.78965	0.249
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	24	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	-0.33021	-0.93696	0.5039	0.83731	1	0.417	0.41	0.246	0.79028	0.248
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_ACETYLATED_NON_HISTONE_PROTEINS	-0.34989	-0.93639	0.5639	0.83692	1	0.2	0.0603	0.188	0.79063	0.248
CHANG_IMMORTALIZED_BY_HPV31_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_IMMORTALIZED_BY_HPV31_DN	-0.33452	-0.93521	0.5341	0.83792	1	0.262	0.128	0.23	0.79391	0.247
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	163	http://www.broadinstitute.org/gsea/msigdb/cards/GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-0.29634	-0.93494	0.5413	0.83674	1	0.233	0.102	0.211	0.79246	0.245
PID_HIF1A_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIF1A_PATHWAY	-0.36301	-0.93485	0.5806	0.83513	1	0.278	0.0738	0.258	0.79073	0.244
KEGG_DNA_REPLICATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DNA_REPLICATION	-0.35159	-0.93429	0.5431	0.83466	1	0.333	0.121	0.293	0.79052	0.243
KANG_FLUOROURACIL_RESISTANCE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_FLUOROURACIL_RESISTANCE_DN	-0.40384	-0.93271	0.5573	0.83669	1	0.438	0.146	0.374	0.79166	0.244
PID_INTEGRIN_A9B1_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_A9B1_PATHWAY	-0.35072	-0.93093	0.5347	0.83928	1	0.25	0.0828	0.23	0.79453	0.248
PID_INTEGRIN3_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN3_PATHWAY	-0.3558	-0.93053	0.5344	0.83846	1	0.333	0.0627	0.313	0.79282	0.246
DELACROIX_RAR_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_TARGETS_UP	-0.30578	-0.9298	0.5483	0.83845	1	0.174	0.0386	0.168	0.79314	0.246
DAZARD_UV_RESPONSE_CLUSTER_G4	20	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G4	-0.34632	-0.9297	0.5512	0.83688	1	0.3	0.164	0.251	0.79143	0.242
KEGG_ASTHMA	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ASTHMA	-0.37573	-0.92779	0.5502	0.83985	1	0.462	0.31	0.319	0.79614	0.245
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	45	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON	-0.31037	-0.92775	0.5542	0.83815	1	0.467	0.29	0.332	0.79444	0.245
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	34	http://www.broadinstitute.org/gsea/msigdb/cards/QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	-0.31666	-0.9277	0.5672	0.83648	1	0.5	0.252	0.375	0.79307	0.243
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_TARGETS_OF_BCR_ABL1_FUSION	-0.34422	-0.92621	0.543	0.83831	1	0.295	0.135	0.256	0.79492	0.244
WALLACE_JAK2_TARGETS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_JAK2_TARGETS_UP	-0.35468	-0.9241	0.5547	0.84162	1	0.2	0.0683	0.187	0.79898	0.246
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	131	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	-0.25361	-0.92313	0.58	0.84216	1	0.229	0.142	0.198	0.80017	0.246
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	298	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	-0.25048	-0.92267	0.5444	0.84149	1	0.295	0.16	0.252	0.79924	0.246
MARZEC_IL2_SIGNALING_UP	105	http://www.broadinstitute.org/gsea/msigdb/cards/MARZEC_IL2_SIGNALING_UP	-0.27305	-0.9216	0.5818	0.84228	1	0.238	0.114	0.212	0.79995	0.246
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	221	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	-0.23044	-0.92049	0.6577	0.84312	1	0.19	0.0929	0.174	0.80194	0.247
ZHAN_MULTIPLE_MYELOMA_SPIKED	20	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_SPIKED	-0.37035	-0.91688	0.5709	0.85009	1	0.35	0.101	0.315	0.80788	0.25
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	22	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED	-0.32449	-0.91684	0.5898	0.8484	1	0.364	0.279	0.263	0.80618	0.249
FINETTI_BREAST_CANCER_KINOME_GREEN	16	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_GREEN	-0.41724	-0.9157	0.5689	0.84936	1	0.5	0.236	0.382	0.808	0.249
ST_GA12_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/ST_GA12_PATHWAY	-0.2999	-0.91492	0.5812	0.84937	1	0.478	0.274	0.347	0.80908	0.249
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	-0.3003	-0.91429	0.6032	0.84913	1	0.0926	0.0052	0.0924	0.80921	0.248
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS	-0.31468	-0.91346	0.6056	0.84944	1	0.256	0.161	0.215	0.80968	0.248
SMITH_LIVER_CANCER	40	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_LIVER_CANCER	-0.31623	-0.91337	0.5728	0.84789	1	0.15	0.0307	0.146	0.808	0.248
YIH_RESPONSE_TO_ARSENITE_C4	17	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C4	-0.34998	-0.91178	0.585	0.84996	1	0.353	0.108	0.315	0.81054	0.248
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	-0.35775	-0.91119	0.5788	0.84962	1	0.227	0.054	0.215	0.80975	0.248
ZHANG_TLX_TARGETS_36HR_DN	182	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_36HR_DN	-0.36328	-0.91099	0.5944	0.84836	1	0.269	0.0752	0.251	0.80843	0.247
REACTOME_COLLAGEN_FORMATION	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_COLLAGEN_FORMATION	-0.34016	-0.91084	0.5495	0.847	1	0.352	0.104	0.316	0.80736	0.247
PLASARI_TGFB1_TARGETS_10HR_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_10HR_UP	-0.26569	-0.90888	0.5989	0.84985	1	0.194	0.0694	0.182	0.81048	0.248
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	282	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	-0.34647	-0.90823	0.5863	0.84959	1	0.216	0.0292	0.213	0.81087	0.247
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	-0.29863	-0.90783	0.6508	0.84882	1	0.194	0.0413	0.186	0.81013	0.247
AMIT_EGF_RESPONSE_480_HELA	157	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_480_HELA	-0.26203	-0.90769	0.5812	0.84741	1	0.344	0.18	0.284	0.80891	0.245
PID_SYNDECAN_1_PATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_1_PATHWAY	-0.35318	-0.90715	0.5801	0.84694	1	0.348	0.0807	0.32	0.80787	0.244
VALK_AML_CLUSTER_16	24	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_16	-0.29372	-0.90625	0.5818	0.84733	1	0.208	0.082	0.191	0.8084	0.244
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	-0.37349	-0.90592	0.578	0.84635	1	0.235	0.0627	0.221	0.80676	0.243
KAAB_FAILED_HEART_ATRIUM_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_FAILED_HEART_ATRIUM_UP	-0.30191	-0.90402	0.6503	0.84911	1	0.444	0.231	0.342	0.8102	0.245
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.33463	-0.90266	0.585	0.85066	1	0.273	0.067	0.255	0.81144	0.246
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	-0.36686	-0.90191	0.5515	0.85071	1	0.342	0.0929	0.312	0.81165	0.246
SESTO_RESPONSE_TO_UV_C3	18	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C3	-0.38908	-0.90065	0.596	0.85182	1	0.222	0.095	0.201	0.81276	0.247
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-0.36626	-0.89957	0.5901	0.85265	1	0.25	0.0601	0.235	0.81372	0.247
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	77	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	-0.29319	-0.8981	0.6218	0.85425	1	0.273	0.0923	0.249	0.81552	0.249
BOYLAN_MULTIPLE_MYELOMA_C_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_UP	-0.26724	-0.89805	0.6218	0.85266	1	0.319	0.14	0.275	0.81394	0.247
BILD_E2F3_ONCOGENIC_SIGNATURE	230	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_E2F3_ONCOGENIC_SIGNATURE	-0.2814	-0.89799	0.6197	0.8511	1	0.222	0.069	0.209	0.81231	0.245
GROSS_HYPOXIA_VIA_ELK3_UP	195	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_UP	-0.25945	-0.89647	0.6257	0.85299	1	0.21	0.0871	0.194	0.81572	0.246
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	-0.29021	-0.89511	0.5996	0.85448	1	0.165	0.038	0.16	0.81786	0.247
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	34	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	-0.28711	-0.89392	0.6028	0.85558	1	0.265	0.127	0.231	0.81972	0.25
DARWICHE_PAPILLOMA_RISK_HIGH_UP	133	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_UP	-0.24126	-0.89391	0.6619	0.85389	1	0.241	0.132	0.21	0.8181	0.246
BROWNE_HCMV_INFECTION_24HR_UP	139	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_24HR_UP	-0.24196	-0.89376	0.6699	0.85254	1	0.259	0.137	0.225	0.81697	0.243
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	-0.31825	-0.89375	0.595	0.85087	1	0.276	0.184	0.225	0.81536	0.241
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	-0.33119	-0.89262	0.6446	0.85189	1	0.412	0.137	0.356	0.81623	0.242
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	-0.36079	-0.89162	0.5951	0.85256	1	0.312	0.165	0.261	0.81772	0.24
VANTVEER_BREAST_CANCER_BRCA1_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_BRCA1_UP	-0.27721	-0.89068	0.6451	0.85302	1	0.273	0.126	0.239	0.81781	0.24
REACTOME_CELL_CYCLE_CHECKPOINTS	107	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE_CHECKPOINTS	-0.32042	-0.88745	0.5695	0.85867	1	0.234	0.0903	0.214	0.82362	0.248
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	-0.2705	-0.8869	0.6712	0.85824	1	0.171	0.104	0.154	0.82309	0.246
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	60	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.29424	-0.88674	0.6202	0.85693	1	0.0833	0.0166	0.0822	0.82182	0.244
DORMOY_ELAVL1_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/DORMOY_ELAVL1_TARGETS	-0.36235	-0.88639	0.6143	0.85607	1	0.375	0.156	0.317	0.82185	0.243
LEE_LIVER_CANCER_MYC_TGFA_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_TGFA_UP	-0.27171	-0.88615	0.624	0.85494	1	0.224	0.0876	0.205	0.82062	0.241
COATES_MACROPHAGE_M1_VS_M2_DN	71	http://www.broadinstitute.org/gsea/msigdb/cards/COATES_MACROPHAGE_M1_VS_M2_DN	-0.26245	-0.88533	0.6895	0.85516	1	0.211	0.0871	0.194	0.82086	0.242
DAIRKEE_TERT_TARGETS_UP	338	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_TERT_TARGETS_UP	-0.22916	-0.88518	0.6205	0.85386	1	0.219	0.134	0.193	0.81931	0.241
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	-0.32327	-0.8848	0.6894	0.85305	1	0.4	0.127	0.35	0.81903	0.24
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	-0.31206	-0.88429	0.603	0.85262	1	0.296	0.104	0.267	0.81877	0.241
DING_LUNG_CANCER_BY_MUTATION_RATE	18	http://www.broadinstitute.org/gsea/msigdb/cards/DING_LUNG_CANCER_BY_MUTATION_RATE	-0.31818	-0.88273	0.7162	0.85451	1	0.222	0.059	0.209	0.82187	0.243
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	264	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	-0.27015	-0.88066	0.6112	0.85751	1	0.189	0.0656	0.179	0.82523	0.244
KEGG_NOTCH_SIGNALING_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NOTCH_SIGNALING_PATHWAY	-0.21684	-0.88065	0.6547	0.85589	1	0.191	0.14	0.165	0.82364	0.242
BAE_BRCA1_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_DN	-0.28588	-0.88049	0.6639	0.85457	1	0.281	0.0988	0.254	0.82258	0.241
REACTOME_MITOTIC_G1_G1_S_PHASES	127	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_G1_G1_S_PHASES	-0.29961	-0.8802	0.5912	0.85363	1	0.228	0.0903	0.209	0.82121	0.239
REACTOME_G1_S_TRANSITION	103	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_S_TRANSITION	-0.31189	-0.88015	0.584	0.8521	1	0.243	0.0903	0.222	0.81964	0.235
AMIT_SERUM_RESPONSE_480_MCF10A	34	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_480_MCF10A	-0.29276	-0.87989	0.631	0.85107	1	0.294	0.168	0.245	0.81808	0.235
JAZAG_TGFB1_SIGNALING_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_DN	-0.2551	-0.87904	0.7639	0.85136	1	0.333	0.167	0.278	0.81931	0.236
DALESSIO_TSA_RESPONSE	21	http://www.broadinstitute.org/gsea/msigdb/cards/DALESSIO_TSA_RESPONSE	-0.31146	-0.87898	0.6194	0.84988	1	0.19	0.0804	0.175	0.81778	0.236
CUI_GLUCOSE_DEPRIVATION	58	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_GLUCOSE_DEPRIVATION	-0.2864	-0.87826	0.6218	0.84989	1	0.121	0.0189	0.119	0.8179	0.233
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	19	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN	-0.32019	-0.87802	0.6769	0.84878	1	0.158	0.0808	0.145	0.81636	0.231
DAZARD_UV_RESPONSE_CLUSTER_G24	26	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G24	-0.32264	-0.87718	0.6414	0.84901	1	0.385	0.119	0.339	0.81723	0.23
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-0.25922	-0.87704	0.6512	0.84773	1	0.216	0.0752	0.201	0.81588	0.229
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	-0.29718	-0.87488	0.6351	0.85089	1	0.24	0.103	0.216	0.82161	0.233
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	28	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON	-0.2725	-0.8721	0.5739	0.85554	1	0.357	0.179	0.294	0.82829	0.236
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	-0.32518	-0.87169	0.6085	0.85481	1	0.267	0.0871	0.244	0.82769	0.236
SANSOM_APC_TARGETS	194	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS	-0.23092	-0.87109	0.7163	0.85463	1	0.155	0.0851	0.143	0.8271	0.236
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	-0.37696	-0.87067	0.6221	0.85395	1	0.279	0.0707	0.26	0.82582	0.234
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	86	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	-0.23443	-0.87053	0.7961	0.85263	1	0.186	0.108	0.167	0.82428	0.232
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	-0.30252	-0.86976	0.6539	0.85282	1	0.296	0.138	0.256	0.82439	0.232
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	61	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	-0.24583	-0.86904	0.7838	0.85288	1	0.328	0.163	0.275	0.82425	0.23
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	-0.30948	-0.86632	0.656	0.85728	1	0.647	0.265	0.476	0.83003	0.235
PAL_PRMT5_TARGETS_UP	194	http://www.broadinstitute.org/gsea/msigdb/cards/PAL_PRMT5_TARGETS_UP	-0.2805	-0.86308	0.631	0.86275	1	0.201	0.0658	0.19	0.83462	0.24
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	38	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	-0.29457	-0.86299	0.6272	0.86139	1	0.316	0.16	0.266	0.83308	0.238
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	-0.32236	-0.85986	0.6471	0.8667	1	0.263	0.0928	0.239	0.84024	0.245
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	213	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	-0.25196	-0.85863	0.6843	0.86789	1	0.263	0.121	0.233	0.84173	0.244
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	294	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	-0.28457	-0.85548	0.6284	0.87316	1	0.119	0.02	0.118	0.84787	0.251
GEORGES_CELL_CYCLE_MIR192_TARGETS	62	http://www.broadinstitute.org/gsea/msigdb/cards/GEORGES_CELL_CYCLE_MIR192_TARGETS	-0.29691	-0.85452	0.6807	0.8737	1	0.306	0.121	0.27	0.84908	0.252
LEE_LIVER_CANCER_SURVIVAL_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_SURVIVAL_DN	-0.29349	-0.85387	0.6459	0.87345	1	0.208	0.0725	0.194	0.84874	0.251
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	-0.38382	-0.85378	0.6423	0.87205	1	0.294	0.0866	0.269	0.84752	0.251
KEGG_RIBOFLAVIN_METABOLISM	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RIBOFLAVIN_METABOLISM	-0.30393	-0.85337	0.7234	0.87137	1	0.438	0.178	0.36	0.84714	0.25
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	-0.30488	-0.85328	0.6879	0.86998	1	0.222	0.0571	0.21	0.84599	0.245
GENTILE_UV_LOW_DOSE_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_LOW_DOSE_UP	-0.28943	-0.85277	0.691	0.86951	1	0.167	0.0582	0.157	0.84537	0.241
SAGIV_CD24_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/SAGIV_CD24_TARGETS_DN	-0.31481	-0.85206	0.6348	0.86947	1	0.422	0.241	0.321	0.84442	0.243
LEONARD_HYPOXIA	46	http://www.broadinstitute.org/gsea/msigdb/cards/LEONARD_HYPOXIA	-0.30695	-0.85129	0.687	0.8695	1	0.196	0.0417	0.188	0.84518	0.244
VERNOCHET_ADIPOGENESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/VERNOCHET_ADIPOGENESIS	-0.29146	-0.85119	0.7451	0.86815	1	0.105	0.0297	0.102	0.84401	0.24
REACTOME_MICRORNA_MIRNA_BIOGENESIS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MICRORNA_MIRNA_BIOGENESIS	-0.33725	-0.85035	0.6484	0.86846	1	0.353	0.158	0.297	0.84473	0.238
PATTERSON_DOCETAXEL_RESISTANCE	27	http://www.broadinstitute.org/gsea/msigdb/cards/PATTERSON_DOCETAXEL_RESISTANCE	-0.286	-0.85001	0.7442	0.86763	1	0.444	0.231	0.342	0.84346	0.238
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	356	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	-0.21492	-0.84879	0.7485	0.8687	1	0.258	0.134	0.228	0.8456	0.238
KIM_HYPOXIA	25	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_HYPOXIA	-0.30692	-0.84835	0.6647	0.86804	1	0.16	0.0328	0.155	0.84448	0.238
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	192	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	-0.24484	-0.84826	0.6892	0.86668	1	0.24	0.115	0.214	0.84338	0.237
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	-0.26935	-0.84613	0.6699	0.86958	1	0.364	0.208	0.289	0.84675	0.239
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	-0.26636	-0.84591	0.7115	0.86849	1	0.171	0.0873	0.157	0.84524	0.237
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	37	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DRUG_METABOLISM_OTHER_ENZYMES	-0.24881	-0.84558	0.7673	0.86762	1	0.216	0.124	0.19	0.84525	0.236
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	-0.31296	-0.84549	0.6508	0.86631	1	0.205	0.0978	0.185	0.84375	0.235
SU_KIDNEY	15	http://www.broadinstitute.org/gsea/msigdb/cards/SU_KIDNEY	-0.31434	-0.84541	0.7109	0.86493	1	0.533	0.358	0.343	0.84274	0.231
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_EARLY_DIFFERENTIATION_GENES_DN	-0.27463	-0.84474	0.7234	0.86481	1	0.286	0.151	0.243	0.84291	0.229
UROSEVIC_RESPONSE_TO_IMIQUIMOD	22	http://www.broadinstitute.org/gsea/msigdb/cards/UROSEVIC_RESPONSE_TO_IMIQUIMOD	-0.43938	-0.84401	0.6378	0.86488	1	0.227	0.0628	0.213	0.84373	0.228
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	44	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	-0.28949	-0.84147	0.7505	0.86884	1	0.25	0.0522	0.237	0.84839	0.235
REACTOME_S_PHASE	104	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_S_PHASE	-0.29197	-0.84146	0.638	0.86734	1	0.231	0.0891	0.211	0.84689	0.231
WHITFIELD_CELL_CYCLE_S	146	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_S	-0.28386	-0.8404	0.6782	0.86806	1	0.281	0.108	0.252	0.84789	0.23
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	-0.25967	-0.84022	0.7471	0.86689	1	0.413	0.214	0.325	0.8464	0.229
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	-0.25684	-0.83706	0.7154	0.87205	1	0.258	0.122	0.227	0.85276	0.235
KEGG_BLADDER_CANCER	40	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BLADDER_CANCER	-0.28754	-0.83689	0.7044	0.87086	1	0.225	0.069	0.21	0.85254	0.231
MARSON_FOXP3_CORE_DIRECT_TARGETS	18	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_CORE_DIRECT_TARGETS	-0.34398	-0.83668	0.6521	0.8698	1	0.167	0.0446	0.159	0.85231	0.228
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	20	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	-0.33811	-0.83618	0.6469	0.86929	1	0.15	0.0185	0.147	0.85171	0.229
LIU_TOPBP1_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_TOPBP1_TARGETS	-0.29513	-0.83601	0.7267	0.86814	1	0.375	0.192	0.303	0.85061	0.227
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	-0.25943	-0.83558	0.7309	0.86758	1	0.171	0.0713	0.159	0.85079	0.227
FERRANDO_TAL1_NEIGHBORS	19	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_TAL1_NEIGHBORS	-0.34671	-0.83553	0.6862	0.86616	1	0.316	0.147	0.27	0.84978	0.226
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	-0.26144	-0.83491	0.7695	0.866	1	0.196	0.0812	0.18	0.84918	0.226
PENG_GLUTAMINE_DEPRIVATION_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUTAMINE_DEPRIVATION_UP	-0.24441	-0.83454	0.7936	0.86523	1	0.194	0.0734	0.18	0.84848	0.225
PID_IL4_2PATHWAY	63	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL4_2PATHWAY	-0.23313	-0.83301	0.7839	0.86686	1	0.254	0.175	0.21	0.85081	0.226
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	-0.2488	-0.83295	0.8327	0.8655	1	0.433	0.238	0.331	0.84945	0.224
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	-0.31678	-0.83116	0.7066	0.86766	1	0.333	0.0814	0.306	0.85123	0.226
ZWANG_DOWN_BY_2ND_EGF_PULSE	217	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_DOWN_BY_2ND_EGF_PULSE	-0.21787	-0.83076	0.7602	0.86696	1	0.272	0.174	0.227	0.85168	0.225
MEISSNER_BRAIN_ICP_WITH_H3K4ME3	30	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_ICP_WITH_H3K4ME3	-0.28204	-0.82952	0.7014	0.868	1	0.4	0.241	0.304	0.85334	0.225
MEISSNER_ES_ICP_WITH_H3K4ME3	31	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_ES_ICP_WITH_H3K4ME3	-0.26465	-0.82939	0.7263	0.86676	1	0.387	0.241	0.294	0.85209	0.223
SCHURINGA_STAT5A_TARGETS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SCHURINGA_STAT5A_TARGETS_DN	-0.32121	-0.82721	0.6974	0.86971	1	0.176	0.0368	0.17	0.85408	0.227
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	-0.28733	-0.82533	0.7248	0.87204	1	0.286	0.109	0.255	0.85653	0.229
ZWANG_EGF_INTERVAL_UP	81	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_INTERVAL_UP	-0.23082	-0.82479	0.8896	0.87163	1	0.21	0.125	0.184	0.85614	0.229
WAKASUGI_HAVE_ZNF143_BINDING_SITES	56	http://www.broadinstitute.org/gsea/msigdb/cards/WAKASUGI_HAVE_ZNF143_BINDING_SITES	-0.26878	-0.82327	0.7389	0.87325	1	0.268	0.112	0.239	0.85845	0.23
MOOTHA_GLYCOLYSIS	20	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_GLYCOLYSIS	-0.2905	-0.8229	0.6738	0.87251	1	0.2	0.0834	0.183	0.85839	0.229
HENDRICKS_SMARCA4_TARGETS_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/HENDRICKS_SMARCA4_TARGETS_UP	-0.26454	-0.8227	0.7396	0.87145	1	0.327	0.16	0.275	0.85737	0.225
WEBER_METHYLATED_LCP_IN_SPERM_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_LCP_IN_SPERM_UP	-0.29487	-0.82261	0.6495	0.87015	1	0.4	0.367	0.253	0.85618	0.222
LIN_MELANOMA_COPY_NUMBER_UP	67	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_MELANOMA_COPY_NUMBER_UP	-0.24795	-0.821	0.7383	0.87184	1	0.269	0.128	0.235	0.85747	0.224
BOSCO_TH1_CYTOTOXIC_MODULE	105	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_TH1_CYTOTOXIC_MODULE	-0.27593	-0.82047	0.6962	0.87141	1	0.238	0.142	0.205	0.85815	0.221
BARRIER_COLON_CANCER_RECURRENCE_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_COLON_CANCER_RECURRENCE_DN	-0.28956	-0.819	0.7571	0.87287	1	0.45	0.22	0.351	0.8586	0.223
GRADE_COLON_AND_RECTAL_CANCER_UP	267	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_AND_RECTAL_CANCER_UP	-0.25093	-0.81837	0.672	0.87267	1	0.195	0.104	0.177	0.85879	0.222
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	-0.26755	-0.81816	0.7398	0.87167	1	0.219	0.0872	0.2	0.85765	0.219
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	-0.29724	-0.81693	0.7395	0.87268	1	0.143	0.0491	0.136	0.85904	0.218
CHEN_LUNG_CANCER_SURVIVAL	24	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LUNG_CANCER_SURVIVAL	-0.28275	-0.81421	0.7752	0.87661	1	0.25	0.0892	0.228	0.86291	0.225
WANG_THOC1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_THOC1_TARGETS_DN	-0.31663	-0.81275	0.7316	0.878	1	0.316	0.0982	0.285	0.86486	0.226
ZAMORA_NOS2_TARGETS_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/ZAMORA_NOS2_TARGETS_UP	-0.2655	-0.81233	0.7023	0.87737	1	0.23	0.122	0.202	0.8647	0.223
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	-0.29791	-0.80868	0.7367	0.88295	1	0.174	0.0309	0.169	0.8713	0.229
ZHAN_MULTIPLE_MYELOMA_CD2_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD2_DN	-0.27444	-0.80688	0.7728	0.885	1	0.273	0.0921	0.248	0.87372	0.23
REACTOME_REGULATORY_RNA_PATHWAYS	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATORY_RNA_PATHWAYS	-0.30953	-0.80646	0.6992	0.88435	1	0.35	0.158	0.295	0.87291	0.23
SENGUPTA_EBNA1_ANTICORRELATED	150	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_EBNA1_ANTICORRELATED	-0.22983	-0.80619	0.807	0.88344	1	0.513	0.31	0.357	0.87212	0.229
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	-0.31971	-0.80434	0.7671	0.88552	1	0.593	0.297	0.417	0.87452	0.229
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	-0.28977	-0.80336	0.7485	0.88601	1	0.5	0.234	0.383	0.87461	0.229
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP	-0.25709	-0.80285	0.7582	0.88554	1	0.5	0.337	0.332	0.87412	0.228
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	-0.25793	-0.80222	0.7882	0.88533	1	0.0714	0.00692	0.071	0.87453	0.228
PID_HNF3B_PATHWAY	44	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HNF3B_PATHWAY	-0.23152	-0.80187	0.8417	0.88458	1	0.386	0.231	0.298	0.87383	0.227
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	-0.24072	-0.80177	0.8178	0.88329	1	0.34	0.185	0.278	0.87259	0.224
NAGY_TFTC_COMPONENTS_HUMAN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NAGY_TFTC_COMPONENTS_HUMAN	-0.29811	-0.80087	0.7137	0.88359	1	0.278	0.156	0.235	0.87306	0.225
BIDUS_METASTASIS_UP	207	http://www.broadinstitute.org/gsea/msigdb/cards/BIDUS_METASTASIS_UP	-0.31689	-0.79999	0.7006	0.88378	1	0.193	0.044	0.187	0.87324	0.223
LI_DCP2_BOUND_MRNA	82	http://www.broadinstitute.org/gsea/msigdb/cards/LI_DCP2_BOUND_MRNA	-0.26161	-0.7983	0.7088	0.88567	1	0.415	0.255	0.31	0.87574	0.224
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	-0.27622	-0.79747	0.75	0.88582	1	0.211	0.0801	0.194	0.87628	0.222
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	-0.25645	-0.79721	0.824	0.88485	1	0.375	0.21	0.297	0.87551	0.221
BIOCARTA_ATM_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ATM_PATHWAY	-0.29929	-0.79714	0.7481	0.88356	1	0.2	0.059	0.188	0.87409	0.22
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	-0.29521	-0.79701	0.6983	0.88236	1	0.161	0.0563	0.152	0.87381	0.216
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	168	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	-0.21293	-0.79601	0.9045	0.8828	1	0.298	0.218	0.235	0.87436	0.215
REACTOME_BASE_EXCISION_REPAIR	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BASE_EXCISION_REPAIR	-0.26329	-0.79402	0.7377	0.88506	1	0.579	0.343	0.38	0.87692	0.217
REACTOME_METABOLISM_OF_NUCLEOTIDES	66	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_NUCLEOTIDES	-0.26218	-0.79401	0.7441	0.88364	1	0.197	0.09	0.18	0.8755	0.215
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	99	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	-0.21408	-0.79394	0.886	0.88237	1	0.293	0.192	0.238	0.8741	0.213
KAUFFMANN_DNA_REPAIR_GENES	221	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPAIR_GENES	-0.23441	-0.79384	0.749	0.88111	1	0.195	0.104	0.176	0.87276	0.211
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	84	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	-0.23895	-0.78957	0.8016	0.88768	1	0.214	0.106	0.192	0.87907	0.22
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	17	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	-0.27437	-0.788	0.8114	0.88906	1	0.353	0.131	0.307	0.88067	0.222
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	-0.275	-0.78547	0.8669	0.89224	1	0.312	0.139	0.269	0.88546	0.222
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	154	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	-0.19837	-0.78372	0.9018	0.89401	1	0.286	0.217	0.225	0.88775	0.222
DANG_REGULATED_BY_MYC_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_REGULATED_BY_MYC_UP	-0.22304	-0.78335	0.8595	0.89325	1	0.242	0.151	0.207	0.88706	0.22
RAMALHO_STEMNESS_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/RAMALHO_STEMNESS_DN	-0.24427	-0.78244	0.8012	0.89344	1	0.239	0.125	0.21	0.88674	0.221
KASLER_HDAC7_TARGETS_1_UP	185	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_1_UP	-0.20577	-0.78228	0.8459	0.89233	1	0.33	0.211	0.263	0.88606	0.22
GOLUB_ALL_VS_AML_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/GOLUB_ALL_VS_AML_UP	-0.26022	-0.78115	0.7827	0.89299	1	0.348	0.139	0.3	0.88585	0.218
MARKS_HDAC_TARGETS_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_HDAC_TARGETS_UP	-0.28542	-0.78114	0.7797	0.8916	1	0.238	0.12	0.21	0.88445	0.215
PID_P38_MK2_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_MK2_PATHWAY	-0.26326	-0.78106	0.755	0.89034	1	0.381	0.211	0.301	0.8833	0.214
WANG_NFKB_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_NFKB_TARGETS	-0.28412	-0.78086	0.8202	0.88927	1	0.5	0.294	0.354	0.88201	0.212
VALK_AML_CLUSTER_7	27	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_7	-0.30252	-0.77925	0.8108	0.89077	1	0.37	0.175	0.306	0.88434	0.214
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	-0.22733	-0.77906	0.7891	0.88972	1	0.194	0.112	0.172	0.88325	0.208
PID_INTEGRIN1_PATHWAY	65	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN1_PATHWAY	-0.27938	-0.77835	0.7759	0.88959	1	0.246	0.084	0.226	0.88315	0.207
XU_AKT1_TARGETS_6HR	27	http://www.broadinstitute.org/gsea/msigdb/cards/XU_AKT1_TARGETS_6HR	-0.30321	-0.77709	0.7276	0.89041	1	0.222	0.0525	0.211	0.88434	0.209
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE	-0.23177	-0.77607	0.8248	0.89082	1	0.5	0.341	0.33	0.88459	0.205
GRADE_METASTASIS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_METASTASIS_DN	-0.25521	-0.77305	0.761	0.89477	1	0.143	0.0664	0.134	0.88949	0.211
PENG_LEUCINE_DEPRIVATION_DN	179	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_LEUCINE_DEPRIVATION_DN	-0.21422	-0.77236	0.7708	0.89464	1	0.218	0.129	0.191	0.88956	0.21
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	-0.31496	-0.77219	0.7697	0.89353	1	0.312	0.0956	0.283	0.8886	0.205
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	-0.23401	-0.77139	0.7972	0.89356	1	0.456	0.26	0.338	0.88921	0.204
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	92	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	-0.21668	-0.76691	0.8291	0.89992	1	0.163	0.095	0.148	0.89588	0.215
BIOCARTA_ARF_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ARF_PATHWAY	-0.29122	-0.76459	0.7976	0.9024	1	0.176	0.059	0.166	0.8983	0.217
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-0.31475	-0.76396	0.7257	0.90211	1	0.2	0.0655	0.187	0.89848	0.218
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	-0.27393	-0.75993	0.8588	0.90764	1	0.0833	0.00589	0.0829	0.90449	0.226
LI_CYTIDINE_ANALOG_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/LI_CYTIDINE_ANALOG_PATHWAY	-0.27485	-0.75936	0.834	0.90721	1	0.2	0.0991	0.18	0.90427	0.223
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	-0.3267	-0.75926	0.8049	0.90599	1	0.105	0.00461	0.105	0.90288	0.222
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	-0.33124	-0.75654	0.825	0.90913	1	0.389	0.141	0.334	0.90603	0.226
VANHARANTA_UTERINE_FIBROID_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_UP	-0.2726	-0.75432	0.8392	0.91137	1	0.25	0.0684	0.233	0.91062	0.231
REACTOME_RNA_POL_III_CHAIN_ELONGATION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_CHAIN_ELONGATION	-0.25534	-0.75386	0.7871	0.91071	1	0.0588	0.00132	0.0588	0.91001	0.229
BIOCARTA_PTDINS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PTDINS_PATHWAY	-0.23894	-0.75342	0.8514	0.91003	1	0.217	0.111	0.193	0.90933	0.227
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	-0.26824	-0.75171	0.834	0.91142	1	0.208	0.0807	0.192	0.9111	0.229
REACTOME_LAGGING_STRAND_SYNTHESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LAGGING_STRAND_SYNTHESIS	-0.28227	-0.75146	0.741	0.91043	1	0.211	0.0871	0.192	0.91031	0.224
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	-0.22787	-0.75141	0.8617	0.90913	1	0.2	0.142	0.172	0.90896	0.221
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	15	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME2	-0.26658	-0.75105	0.9004	0.90835	1	0.4	0.224	0.31	0.90793	0.214
ZHOU_TNF_SIGNALING_30MIN	51	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_TNF_SIGNALING_30MIN	-0.22437	-0.74906	0.8463	0.91017	1	0.176	0.0931	0.16	0.9088	0.219
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	-0.32015	-0.74837	0.7889	0.90993	1	0.182	0.0541	0.172	0.90843	0.216
KRIEG_HYPOXIA_VIA_KDM3A	50	http://www.broadinstitute.org/gsea/msigdb/cards/KRIEG_HYPOXIA_VIA_KDM3A	-0.29134	-0.74692	0.8021	0.91088	1	0.28	0.163	0.235	0.91087	0.216
KOBAYASHI_EGFR_SIGNALING_6HR_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_6HR_DN	-0.33081	-0.74563	0.7636	0.91155	1	0.278	0.0936	0.252	0.91113	0.218
REACTOME_RNA_POL_I_TRANSCRIPTION	60	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION	-0.24264	-0.74497	0.813	0.91124	1	0.383	0.238	0.293	0.91111	0.212
ELVIDGE_HYPOXIA_DN	139	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_DN	-0.22242	-0.74476	0.8723	0.91018	1	0.345	0.181	0.285	0.90992	0.208
REACTOME_POTASSIUM_CHANNELS	95	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POTASSIUM_CHANNELS	-0.21824	-0.74215	0.9293	0.91282	1	0.242	0.165	0.203	0.91335	0.21
KEGG_PYRIMIDINE_METABOLISM	89	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PYRIMIDINE_METABOLISM	-0.20531	-0.74173	0.8762	0.91205	1	0.18	0.114	0.16	0.9127	0.209
REACTOME_SYNTHESIS_OF_DNA	88	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_DNA	-0.25576	-0.74122	0.7446	0.91143	1	0.205	0.0891	0.187	0.91158	0.207
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	-0.3193	-0.7377	0.7853	0.91539	1	0.429	0.244	0.324	0.91552	0.214
KOINUMA_COLON_CANCER_MSI_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/KOINUMA_COLON_CANCER_MSI_UP	-0.31736	-0.73628	0.7848	0.91616	1	0.188	0.0492	0.178	0.91609	0.214
VILIMAS_NOTCH1_TARGETS_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/VILIMAS_NOTCH1_TARGETS_UP	-0.28501	-0.73599	0.8068	0.91524	1	0.235	0.114	0.209	0.91501	0.21
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	116	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	-0.22183	-0.73573	0.831	0.91425	1	0.25	0.216	0.197	0.91447	0.206
ROY_WOUND_BLOOD_VESSEL_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/ROY_WOUND_BLOOD_VESSEL_DN	-0.32279	-0.73498	0.8096	0.91405	1	0.318	0.108	0.284	0.91374	0.205
BIOCARTA_DC_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_DC_PATHWAY	-0.27951	-0.73347	0.822	0.91503	1	0.273	0.244	0.206	0.91532	0.207
REACTOME_BETA_DEFENSINS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BETA_DEFENSINS	-0.31015	-0.73322	0.8084	0.91401	1	0.235	0.163	0.197	0.91418	0.2
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	15	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON	-0.25227	-0.73159	0.8294	0.91505	1	0.267	0.211	0.211	0.91573	0.2
LUI_THYROID_CANCER_CLUSTER_4	15	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_CLUSTER_4	-0.31868	-0.73082	0.7984	0.91483	1	0.333	0.145	0.285	0.91469	0.202
AZARE_STAT3_TARGETS	22	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_STAT3_TARGETS	-0.26776	-0.73044	0.8785	0.91403	1	0.227	0.0672	0.212	0.91423	0.199
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	32	http://www.broadinstitute.org/gsea/msigdb/cards/CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	-0.24289	-0.72629	0.8693	0.91882	1	0.125	0.0283	0.122	0.92035	0.204
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	-0.29884	-0.72555	0.8551	0.9185	1	0.2	0.0776	0.185	0.92001	0.203
VILIMAS_NOTCH1_TARGETS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/VILIMAS_NOTCH1_TARGETS_DN	-0.28966	-0.72479	0.7722	0.9183	1	0.25	0.22	0.195	0.92074	0.201
GUILLAUMOND_KLF10_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/GUILLAUMOND_KLF10_TARGETS_UP	-0.21676	-0.72247	0.9426	0.92025	1	0.255	0.137	0.221	0.92192	0.204
PID_INTEGRIN_CS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_CS_PATHWAY	-0.268	-0.72179	0.8655	0.91985	1	0.44	0.214	0.346	0.92196	0.2
ONDER_CDH1_TARGETS_3_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_3_DN	-0.26751	-0.71919	0.8577	0.92212	1	0.291	0.162	0.244	0.92445	0.205
DOANE_RESPONSE_TO_ANDROGEN_UP	174	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_RESPONSE_TO_ANDROGEN_UP	-0.17965	-0.71756	0.9804	0.92309	1	0.236	0.155	0.201	0.92503	0.206
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	61	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	-0.27028	-0.71711	0.7412	0.92232	1	0.18	0.0787	0.167	0.92404	0.204
GAJATE_RESPONSE_TO_TRABECTEDIN_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/GAJATE_RESPONSE_TO_TRABECTEDIN_DN	-0.29273	-0.71373	0.856	0.92558	1	0.389	0.188	0.316	0.92832	0.207
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	-0.20519	-0.71151	0.9452	0.92721	1	0.138	0.0868	0.127	0.93082	0.208
REACTOME_M_G1_TRANSITION	76	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_M_G1_TRANSITION	-0.24824	-0.71102	0.788	0.92651	1	0.263	0.121	0.232	0.92974	0.203
KEGG_BASE_EXCISION_REPAIR	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BASE_EXCISION_REPAIR	-0.22263	-0.71042	0.8608	0.92593	1	0.219	0.122	0.192	0.92896	0.203
ABBUD_LIF_SIGNALING_1_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/ABBUD_LIF_SIGNALING_1_DN	-0.27384	-0.71025	0.9531	0.92481	1	0.231	0.0867	0.211	0.92826	0.199
HEIDENBLAD_AMPLICON_12P11_12_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_12P11_12_DN	-0.26367	-0.71023	0.8557	0.92349	1	0.381	0.26	0.282	0.92693	0.192
URS_ADIPOCYTE_DIFFERENTIATION_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/URS_ADIPOCYTE_DIFFERENTIATION_DN	-0.26327	-0.70996	0.8317	0.92254	1	0.241	0.0929	0.219	0.92586	0.188
REACTOME_GAP_JUNCTION_TRAFFICKING	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GAP_JUNCTION_TRAFFICKING	-0.24506	-0.7067	0.9072	0.9255	1	0.36	0.229	0.278	0.92918	0.197
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	-0.25308	-0.70148	0.8608	0.93106	1	0.353	0.167	0.294	0.93547	0.208
RADAEVA_RESPONSE_TO_IFNA1_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/RADAEVA_RESPONSE_TO_IFNA1_UP	-0.27021	-0.69921	0.7631	0.93253	1	0.255	0.125	0.224	0.93596	0.207
KEGG_STARCH_AND_SUCROSE_METABOLISM	35	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_STARCH_AND_SUCROSE_METABOLISM	-0.20748	-0.69886	0.9505	0.93165	1	0.229	0.143	0.196	0.93478	0.204
ZHANG_INTERFERON_RESPONSE	22	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_INTERFERON_RESPONSE	-0.34607	-0.69847	0.749	0.93083	1	0.227	0.0602	0.214	0.93415	0.199
NIELSEN_LEIOMYOSARCOMA_CNN1_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_CNN1_UP	-0.31671	-0.69743	0.8566	0.93078	1	0.316	0.109	0.282	0.9336	0.197
KEGG_OLFACTORY_TRANSDUCTION	110	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OLFACTORY_TRANSDUCTION	-0.19075	-0.69635	0.7868	0.9308	1	0.4	0.397	0.242	0.93357	0.193
HAHTOLA_CTCL_PATHOGENESIS	15	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_CTCL_PATHOGENESIS	-0.33255	-0.69595	0.8091	0.92998	1	0.467	0.228	0.36	0.93257	0.186
CROMER_TUMORIGENESIS_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_TUMORIGENESIS_UP	-0.275	-0.69425	0.8352	0.93074	1	0.228	0.0828	0.21	0.93384	0.185
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	-0.22688	-0.69253	0.8848	0.93153	1	0.0526	0.00132	0.0526	0.93465	0.186
STARK_HYPPOCAMPUS_22Q11_DELETION_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/STARK_HYPPOCAMPUS_22Q11_DELETION_DN	-0.24854	-0.691	0.8472	0.93205	1	0.625	0.352	0.405	0.93516	0.183
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	-0.21895	-0.68465	0.8586	0.93827	1	0.087	0.0502	0.0827	0.94172	0.202
BIOCARTA_MTA3_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MTA3_PATHWAY	-0.22506	-0.68372	0.8907	0.93807	1	0.222	0.123	0.195	0.94151	0.198
DASU_IL6_SIGNALING_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_UP	-0.2231	-0.67914	0.9056	0.9419	1	0.321	0.234	0.247	0.94558	0.205
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	-0.26599	-0.67515	0.9197	0.94502	1	0.533	0.266	0.392	0.94837	0.213
WILCOX_RESPONSE_TO_PROGESTERONE_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/WILCOX_RESPONSE_TO_PROGESTERONE_DN	-0.23256	-0.67342	0.9314	0.94556	1	0.492	0.276	0.358	0.94927	0.214
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	26	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	-0.27075	-0.6716	0.9254	0.94614	1	0.423	0.193	0.342	0.94955	0.212
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	-0.252	-0.66753	0.9277	0.94919	1	0.148	0.0517	0.141	0.95301	0.222
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	-0.23681	-0.66591	0.8923	0.94954	1	0.25	0.153	0.212	0.95301	0.22
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	-0.2595	-0.66257	0.8988	0.9517	1	0.158	0.0664	0.148	0.95569	0.223
MEISSNER_NPC_ICP_WITH_H3K4ME3	17	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_ICP_WITH_H3K4ME3	-0.24212	-0.66109	0.9074	0.95189	1	0.412	0.241	0.313	0.95589	0.221
BOWIE_RESPONSE_TO_TAMOXIFEN	18	http://www.broadinstitute.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_TAMOXIFEN	-0.32955	-0.65464	0.7952	0.95682	1	0.278	0.0602	0.261	0.96068	0.236
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	-0.2461	-0.65441	0.9592	0.95571	1	0.269	0.177	0.222	0.9595	0.23
REACTOME_GLUCONEOGENESIS	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCONEOGENESIS	-0.21335	-0.64951	0.8968	0.959	1	0.355	0.241	0.27	0.96281	0.235
WANG_TNF_TARGETS	22	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TNF_TARGETS	-0.21365	-0.64928	0.9405	0.95789	1	0.409	0.304	0.285	0.96157	0.227
MORI_PLASMA_CELL_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PLASMA_CELL_DN	-0.25076	-0.64572	0.9394	0.9598	1	0.276	0.135	0.239	0.96456	0.231
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	-0.20706	-0.64519	0.8863	0.95894	1	0.404	0.268	0.297	0.96331	0.225
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	-0.23617	-0.64074	0.9449	0.96155	1	0.429	0.276	0.311	0.96558	0.23
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	29	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	-0.27302	-0.63471	0.8935	0.96538	1	0.207	0.0705	0.193	0.97051	0.243
REACTOME_SHC_RELATED_EVENTS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_RELATED_EVENTS	-0.23646	-0.63423	0.9458	0.96444	1	0.412	0.251	0.309	0.96965	0.234
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	40	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_SPLICING_MINOR_PATHWAY	-0.212	-0.63391	0.8686	0.96336	1	0.175	0.158	0.148	0.96834	0.227
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	-0.22579	-0.63008	0.9845	0.96508	1	0.308	0.157	0.26	0.97038	0.226
LIANG_SILENCED_BY_METHYLATION_2	51	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_SILENCED_BY_METHYLATION_2	-0.26416	-0.6287	0.8723	0.96479	1	0.157	0.0522	0.149	0.96956	0.215
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	80	http://www.broadinstitute.org/gsea/msigdb/cards/GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.2302	-0.62338	0.9364	0.96756	1	0.2	0.0911	0.183	0.97277	0.228
KIM_ALL_DISORDERS_DURATION_CORR_DN	140	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_DURATION_CORR_DN	-0.17634	-0.61997	0.901	0.96878	1	0.193	0.151	0.165	0.97391	0.23
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	16	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	-0.22305	-0.61908	0.9284	0.96814	1	0.5	0.299	0.351	0.97294	0.214
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	23	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	-0.2393	-0.61488	0.9362	0.96983	1	0.261	0.135	0.226	0.97542	0.218
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	-0.19961	-0.61144	0.9883	0.9708	1	0.481	0.287	0.344	0.97602	0.22
REACTOME_IL_2_SIGNALING	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL_2_SIGNALING	-0.19844	-0.60636	0.9591	0.97284	1	0.0732	0.0179	0.072	0.97807	0.221
AMIT_EGF_RESPONSE_120_HELA	65	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_120_HELA	-0.19328	-0.60209	0.9679	0.97434	1	0.385	0.272	0.281	0.97897	0.229
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	-0.2389	-0.59621	0.9562	0.97654	1	0.333	0.209	0.264	0.9817	0.235
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	-0.22684	-0.59115	0.9747	0.97812	1	0.367	0.273	0.267	0.98338	0.239
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	30	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	-0.23612	-0.59074	0.954	0.97702	1	0.2	0.123	0.176	0.98231	0.225
ZHU_CMV_8_HR_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_8_HR_UP	-0.23573	-0.58168	0.9146	0.98051	1	0.213	0.108	0.19	0.98523	0.246
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	-0.25277	-0.57111	0.9483	0.98437	1	0.106	0.0442	0.102	0.98865	0.278
REACTOME_SHC_MEDIATED_SIGNALLING	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_MEDIATED_SIGNALLING	-0.22814	-0.56353	0.9644	0.98636	1	0.4	0.251	0.3	0.99015	0.288
PID_INTEGRIN2_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN2_PATHWAY	-0.20379	-0.56351	0.9769	0.98504	1	0.143	0.0923	0.13	0.98881	0.255
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINE_LIGAND_BINDING_RECEPTORS	-0.21233	-0.56327	0.9532	0.9838	1	0.278	0.251	0.208	0.98757	0.229
WU_HBX_TARGETS_2_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_2_DN	-0.21821	-0.56022	0.9433	0.98376	1	0.25	0.175	0.206	0.98754	0.21
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	-0.19965	-0.55455	0.9921	0.98467	1	0.263	0.173	0.218	0.98816	0.199
KEGG_ALLOGRAFT_REJECTION	33	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALLOGRAFT_REJECTION	-0.20744	-0.53668	0.957	0.98946	1	0.182	0.0978	0.164	0.99273	0.263
KEGG_AUTOIMMUNE_THYROID_DISEASE	46	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AUTOIMMUNE_THYROID_DISEASE	-0.19092	-0.51282	0.9728	0.99431	1	0.152	0.0978	0.138	0.99702	0.359
BIOCARTA_NO2IL12_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NO2IL12_PATHWAY	-0.20955	-0.50441	0.9468	0.99477	1	1	0.791	0.21	0.99695	0.35
DAZARD_UV_RESPONSE_CLUSTER_G28	18	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G28	-0.23943	-0.50068	0.96	0.99416	1	0.167	0.0936	0.151	0.9965	0.299
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	29	http://www.broadinstitute.org/gsea/msigdb/cards/BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.21014	-0.49256	0.9395	0.99432	1	0.207	0.136	0.179	0.99637	0.258
WEBER_METHYLATED_HCP_IN_SPERM_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_SPERM_UP	-0.18176	-0.47577	0.9784	0.99556	1	0.529	0.392	0.322	0.99723	0.251
WORSCHECH_TUMOR_REJECTION_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/WORSCHECH_TUMOR_REJECTION_UP	-0.15054	-0.39187	1	1	1	0.333	0.273	0.243	1	0.722
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES	-0.15309	-0.37311	1	0.99933	1	0.435	0.31	0.3	1	0.502
